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ii 
Abstract 
Lung cancer is the leading cause of cancer related death. Radiation therapy is a prominent 
treatment method but leads to adverse consequences. Radiation-Induced Lung Injury (RILI) 
is the primary adverse consequence that limits further radiation therapy and develops in 5-
37% of the treated patients. RILI proceeds in two distinct phases: a) early and reversible 
Radiation Pneumonitis (RP), and b) late and irreversible radiation fibrosis. Clinically, Dose 
Volume Histogram (DVH) parameters derived from radiation therapy planning stage are 
used to determine outcome and severity of RP but have been demonstrated to possess a very 
low predictive power. Computed Tomography (CT) is the most commonly used modality for 
the imaging of RP, but often only detects very late RP that leaves little room for intervention 
to abort the progress to irreversible radiation fibrosis. Early detection of RP using imaging 
may allow for interventional treatment and management of the disease and the associated 
symptoms in a better manner. Improvement in Dynamic Nuclear Polarization (DNP) 
technology has led to advancement of hyperpolarized 13-Carbon-Magnetic Resonance 
Imaging (13C-MRI). In this thesis, we present the investigation of early detection of RP with 
13C-MRI in an animal model with the use of hyperpolarized 13C-pyruvate. A pilot study 
demonstrated the proof of concept along with a qualitative histological confirmation. 13C-
MRI data and histology data were collected 2 weeks post irradiation of whole thorax in 
rodents. In the subsequent study, regional and longitudinal 13C-MRI and quantitative 
histology data were analyzed to demonstrate the early organ-wide response of RP. These data 
were collected at day 5, 10, 15 and 25 post conformal irradiation of the right rodent lung. 
Finally, we demonstrate a novel approach to map pH using hyperpolarized 13C-bicarbonate 
with the use of spiral-Iterative Decomposition of water and fat with Echo Asymmetry and 
Least squares estimation (IDEAL) pulse sequence. Validation of this approach by 
comparison to Chemical Shift Imaging (CSI) pH measurement and standard pH measurement 
with the aid of phantoms along with hyperpolarized 13C-bicarbonate is presented. pH 
mapping may play a role in the staging and therapeutic intervention of cancer.  
Keywords: Hyperpolarized 13C, 13C-pyruvate, 13C-lactate, 13C-MRI, Radiation-Induced 
Lung Injury, Radiation Pneumonitis, 13C-bicarbonate, 13C-carbon dioxide, pH mapping, 
cancer pH, IDEAL   
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Chapter 1: Introduction 
This chapter provides the introduction and motivation for the work presented in this thesis. A 
review of healthy lung physiology, Radiation-Induced Lung Injury and radiopathology of the 
irradiated lung is provided in sections 1.2, 1.3 and 1.4. Section 1.7 provides an introductory 
review of basic physics of Magnetic Resonance Imaging (MRI). Section 1.8 describes the 
hyperpolarization process and biological context for the 13C-susbstrates used in the thesis. To 
put the research work within context, clinical and functional imaging methods for Radiation-
Induced Lung Injury are introduced in Sections 1.5 and 1.6. Organization of the thesis is 
provided towards the end of this chapter (section 1.9).  
 
1.1 Overview and Motivation 
Recent developments in the hyperpolarization process have led to the imaging of Carbon-13 
(13C)-labelled substrates and their corresponding downstream metabolites in vivo in real time 
(1), enabling the study of specific enzyme-catalyzed reactions coupled to metabolism. 
Changes in metabolism precede anatomical and functional changes and can help identify 
diseases at an earlier time point than conventional imaging. 13C-MRI has been moderately 
successful at detection of abnormal metabolism in cancer at a pre-clinical level and is now 
moving towards clinical application, most recently in the form of a phase I clinical trial for 
prostate cancer. (2) Lung cancer is responsible for the most cancer related deaths, with 
radiation therapy as one of the prominent methods of treatment. Up to 37% of the lung 
cancer patients treated with radiation therapy develop Radiation-Induced Lung Injury (RILI). 
(3) In this thesis, 13C-MRI is used to image metabolism in real time in a rat model of RILI. 
The aim of the work was to detect regional metabolic changes in RILI prior to any functional 
or anatomical changes. Additional work towards pH mapping with 13C-MRI was also 
performed with application towards diseases with abnormal regional pH such as cancer.  
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1.2 Healthy Lung Physiology 
The primary function of the lung is to facilitate gas exchange, specifically absorption of 
oxygen and elimination of carbon dioxide. The lung enables this process using a large 
surface area for the contact of air and blood separated by a very thin tissue boundary. (4) The 
structure of the lung begins with the largest airway called the trachea, which progressively 
branches twenty-three times into narrower airways until the alveolar level is reached. (5) 
Alveoli are tiny air sacs consisting of a very thin tissue boundary (or septum) that is the site 
of gas exchange. Driven primarily by diffusion, gas exchange takes place as the inhaled 
oxygen is able to diffuse into the capillaries from the alveoli and carbon dioxide is able to 
diffuse from capillaries to the alveoli. There are on average 480 million alveoli in the human 
lung (6) and the total air exchange surface area is approximated to 130 m2. (4) The interested 
reader is referred to “Respiratory physiology: The Essentials” by John B. West (7) for 
comprehensive details on lung function, ventilation and gas exchange.  
 
1.3 Lung Function Tests  
A variety of respiratory diseases can lead to the impairment of lung function. Pulmonary 
Function Tests (PFT) are used to evaluate global function of the diseased lung. The most 
common PFT is spirometry, which measures airflow as a function of time during both the 
inspiration phase and the expiration phase of a breathing cycle and is widely considered the 
gold standard for measuring lung function. (8) Forced Expiration Volume in One Second 
(FEV1), the maximum volume of air expired during forced expiration in one second is used 
to evaluate severity of the disease. In addition, plethysmography is widely used to measure 
static lung volumes. Spirometry and plethysmography are quick and inexpensive but do not 
provide any information about gas exchange. Measurement of Diffusing Capacity of Carbon 
Monoxide (DLCO) provides insight into diffusion of gases across the alveolar membrane by 
quantifying the alveolar volume and the concentration of carbon monoxide in exhaled gas 
following inhalation of a known quantity of carbon monoxide gas. (9) Measurement of 
Partial Pressure of Oxygen in Arterial Blood (paO2) is used to identify the global level of 
hypoxia in the body. A paO2 measurement of less than 60 mmHg is considered as clinical 
hypoxia. (10) All these tests measure global lung function and overall health of the 
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respiratory system, but lack regional information. Spatial localization of the underlying 
disease may provide a better insight into the disease pathology. Improved sensitivity may 
also aid in earlier detection of the underlying disease. 
 
1.4 Radiation Therapy of Lung Cancer  
1.4.1 Lung Cancer  
Lung cancer is responsible for the highest number of cancer deaths in the US population (11) 
and in the global population. (12) Smoking has been established as one of the largest risk 
factors globally and is responsible for lung cancer in 80% and 50% of males and females 
respectively. (13) There is no known screening test for lung cancer. The diagnosis usually 
comes after presentation of clinical symptoms such as tiredness, lack of energy, shortness of 
breath, coughing, lack of appetite, hemoptysis, chest pain and dyspnea. (14) The prognosis 
for lung cancer is very poor with global 5-year survival for lung cancer patients ranging 
between 6-14% for men and 7-18% for women. (15) Lung cancer can be broadly divided into 
two major categories with about 85 – 90% of the cases categorized as Non-Small Cell Lung 
Carcinoma (NSCLC) and 10 – 15% of the cases as Small Cell Lung Carcinoma (SCLC). (16) 
Internationally accepted staging of lung cancer is based primarily on three categories: T- 
primary tumour, N-regional lymph nodes, and, M-distant metastasis, known as the (TNM) 
classification system. T ranges from one to four based on the size and location of the primary 
tumour within the thorax. N is assigned a value from zero to three based on the metastasis 
and location of regional lymph nodes within the thorax. M is assigned a one if a distant 
metastasis is present, zero otherwise. (17) Following the TNM classification of the lung 
cancer, it is grouped into stages ranging from stage I to stage IV where each overall stage has 
similar treatment options and survival. For example, stage II could be one of T1N1M0, 
T2N1M0 and T3N0M0.  
1.4.2 Treatment of Lung Cancer  
Surgical resection, radiation therapy and chemotherapy are the three most common treatment 
options for lung cancer patients. Radiation therapy is one of the most prominent methods 
used for treatment of lung cancer for curative as well as palliative care. It is used in 49.3% of 
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the NSCLC patient population and 47% of the SCLC patient population. (18) Standard 
treatment for stages I and II lung cancers is a surgical operation. (19) Adjuvant therapy may 
be offered to the patient post resection in the form of radiation therapy or chemotherapy. (20, 
21) Patients unfit for surgery due to poor PFT are treated with radiation therapy. Curative 
therapy for stage III lung cancer is provided with chemotherapy in combination with 
radiation therapy or surgery. Treatment for Stage IV cancer patients is a combination of 
chemotherapy and palliative radiation therapy. (19, 22)  
1.4.3 Radiation-Induced Lung Injury (RILI)  
Radiation therapy for the treatment of lung cancer is used with a curative intent, but can lead 
to adverse consequences. The therapeutic radiation beam is not only damaging to the lung 
cancer but often the healthy tissue around it as well. As the lung is an extremely 
radiosensitive organ, (23) irradiation of the healthy tissue leads to unintended consequences 
known as RILI. This leads to a significant degradation in quality of life of the patient due to 
symptoms such as dyspnea, cough and fever that accompany decline in lung function. (3) In 
addition, onset of RILI is the primary criterion that limits the allowable therapeutic dose. 
RILI occurs in up to 37% of lung cancer patients treated with radiation therapy and the 
incidence of moderate to severe injury ranges from 10-20%. (24) The three-year survival rate 
for subjects with severe RILI is a dismal 0%. (25) 
RILI occurs in two distinct stages, the Radiation Pneumonitis (RP) phase and the radiation 
fibrosis phase. A schematic of pathological events post radiation therapy leading to RP and 
fibrosis is shown in Figure 1-1. RP is the initial acute phase and presents with symptoms of 
shortness of breath, cough and mild fever that onset 1 – 6 months after the beginning of 
radiation therapy. (26) RP is marked by inflammation and macrophage accumulation and 
proliferation, leading to capillary obstruction and septal thickening. (3, 27) If RP is not 
treated in time with steroids, (26) the persistence of Reactive Oxygen Species (ROS), 
hypoxia, proliferation of macrophages and cytokines transform RP in to radiation fibrosis. 
The chronic phase of radiation fibrosis is an irreversible process and typically occurs months 
to years after the onset of radiation therapy and is marked by progressive chronic dyspnea. 
(26) 
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1.4.4 Radiopathology of Irradiated Lung Tissue  
Ionizing radiation to the lung inflicts injury primarily to type II pneumocytes and vascular 
endothelial cells leading to leakage of protein rich plasma into alveolar space resulting in 
edema and infiltration by inflammatory macrophages. Histological evidence of edema and 
inflammation during RP is shown in Figure 1-2. These changes cause impairment of gas 
exchange and reduction in lung compliance. (28-30) At a cellular level, tissue hypoxia is an 
important contributing factor in mediation of the inflammatory process and the onset of RP. 
(31) Clinically, paO2 has been used as an indicator of hypoxia with a measurement of below 
60 mmHg deemed as clinical hypoxia (10). Persistence of hypoxia has been reported post 
radiation therapy (32, 33) and recent studies suggest that it may exacerbate lung injury 
further. (26) Immunohistochemical analysis in animal models of RILI reveals underlying 
changes in resident alveolar macrophages, inflammatory cytokines, type II pneumocytes, 
endothelial cells and fibroblasts. (34, 35) During RP, an inflammatory reaction takes place in 
response to the radiation damage and as a result leukocytes are recruited from outside the 
radiation field. (36) Fibroblasts are the first to respond and release cytokines along with 
chemotactic factors. Circulating monocytes follow to the site of the injury and differentiate 
into macrophages. (37) Macrophages are a source of ROS and the inflammatory cytokines. 
The growth factors affect the endothelial cells and may lead to angiogenesis. In addition, 
mast cells may also be present and lead to synthesis and storage of histamine and cytokines. 
(35) Persistence of hypoxia and cytokines leads to chronic oxidative stress and tissue 
remodelling which instead of restoring the healthy lung tissue results in radiation fibrosis.  
The onset of hypoxia alters the process of glycolysis in a cell by switching from 
predominantly aerobic respiration to anaerobic respiration. As the oxygen availability 
diminishes, anaerobic respiration starts to play a bigger role in the production of energy 
molecule Adenosine Triphosphate (ATP) in the cell. This phenomenon is known as the 
Pasteur effect and leads to a higher production of lactate inside the cell. (38) Further evidence 
on Hypoxia Inducible Factor-1 (HIF-1) that presents with onset of hypoxia suggests that it 
regulates glycolysis for additional lactate production to ensure cell survival. (39)  
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Figure 1-1: Radiation therapy leads to tissue damage that induces an inflammatory reaction 
and macrophage activation and accumulation. Hypoxia mediates these processes and further 
leads to cytokine and ROS production during Radiation Pneumonitis. These progressions 
cause additional tissue damage to type II pneumocytes and endothelial cells. If hypoxia and 
cytokines persist, over time they lead to chronic oxidative stress and tissue remodelling that 
results in irreversible lung fibrosis. Adapted from reference (26).  
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Figure 1-2: Haematoxylin and eosin stained sections of healthy lung (left) and irradiated 
lung (right) from C57BL/6J mice post 12.5 Gy dose at 100× magnification (top) and 180× 
magnification (bottom) showing edema and inflammation during RP (2 weeks post-
irradiation). Arrow 1 shows alveolar wall thickening, arrow 2 shows interstitial edema and 
arrow 3 shows peribronchial inflammation. Adapted from reference (40). 
 
1.5 Clinical Diagnosis of Radiation-Induced Lung Injury 
1.5.1 Epidemiology and Risk Factors  
As described earlier, RILI develops in up to 37% of lung cancer patients post treatment with 
radiation therapy and moderate to severe injury develops in 10-20% of lung cancer patients. 
(24) Multiple risk factors for RILI have been identified from the existing data in the 
literature. Some of these include pulmonary dysfunction (paO2 < 80 mmHg), poor PFT 
outcome, concurrent chemotherapy and radiation therapy, primary tumour located in lower-
lobe of lung, large treatment volume, high dose rate, high dose and elevated levels of 
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Transforming Growth Factor Beta One (TGFβ1). (25, 41-45) These risk factors can be 
categorized as either treatment-specific or patient-specific as shown in Table 1-1. 
treatment-specific patient-specific 
• large treatment volume  
• high dose and dose rate 
• concurrent chemoradiation with 
chemotherapy drugs such as: 
cisplatin, paclitaxel, docetaxel and 
mitomycin C 
• poor performance status  
• smoking history and pulmonary 
dysfunction (paO2 < 80) 
• old age, > 60 years 
• primary tumour located in lower 
lobe 
• elevation of TGFβ1 post treatment  
Table 1-1: Risk factors for development of Radiation Pneumonitis post radiation therapy. 
Adapted from reference (46) 
Despite the identification of risk factors, clear predictive relationships between risk factors 
and RP have not been established. (47) Although widespread use of 3D-Computed 
Tomography (CT) has led to improvements in dose planning accuracy whereby high dose is 
delivered to the target tissue (e.g. tumour) and minimal dose is delivered to the surrounding 
healthy tissue, RILI is still not predictable.  Dose Volume Histogram (DVH) parameters can 
be helpful and conveniently generated from the 3D-CT plans. Generation of DVH parameters 
and their implication to RILI are discussed further in the next section.  
1.5.2 Dose Volume Histogram Parameters  
DVH parameters provide a cumulative dose-volume relationship for single or paired organs 
in a graphic and mathematical plot. The 3D dose plan from CT is converted to a 2D format 
that is easier to visualize for dose to the tumour and the critical structures around it. This 
allows for easier identification of dose threshold to the volume of tumour and the volume of 
healthy tissue. (46) The major drawback of DVH parameters is the lack of 3D spatial volume 
and the assumption that all spatial volumes are equal in function. Figure 1-3 shows a 
representative DVH for treatment of lung tumour with dose-volume plotted as a function of 
total dose for various tissues as well as the planning target volume i.e. tumour and 
surrounding tissue. 
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Figure 1-3: Example of DVH representation for a T1bN0M0 lung tumo r. The planning 
target volume (PTV) encompasses the tumour and 95% of its volume receives a do e of 70 
Gy while the dose to organs at risk is minimized. The visual representation of DVH makes it 
easier to interpret the dose-volume relationship to target and organs at risk. Adapted from 
reference (48). 
Several DVH parameters have been developed to simplify the complex 3D dose plan. The 
! !"#$  parameter is defined as the percent of total CT-defined healthy lung receiving more 
than a threshold dose such as 20 Gy, 25 Gy and 30 Gy denoted by ! !" , ! !"  and ! !"  
respectively. Mean Lung Dose (MLD) is defined as the average dose to the entire lung 
volume. In addition, mathematical models have been developed to simulate another DVH 
parameter called the Normal Tissue Complication Probability (NTCP), which has been used 
to assess the risk of RP. (49, 50) Both ! !"#$  and MLD have been widely assessed for their 
RP predictive power. (47, 51). An extensive retrospective and prospective study by 
Rodrigues et. al. has been carried out to assess the predictive nature of DVH parameters to 
RP. (47) According to this study, although DVH parameters correlate with risk factors, none 
demonstrate a predictive power fo RP. As a result, further research is needed to evaluate RP 
and perhaps at the moment, early detection of RP with imaging may the best method to 
manage the disease and the associated symptoms.  
!"#$%&’()*+’
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1.5.3 Signs, Symptoms and Radiographic Findings  
Radiation Pneumonitis can manifest as a symptomatic or as an asymptomatic injury.  
Symptoms of the injury can start as soon as 1 month and as late as 6 months post radiation 
therapy, but often appear at 2-3 months after the treatment. Dyspnea is the most prominent 
symptom of RP and can progress into severe respiratory illness. Several other symptoms such 
as hemoptysis, cough, fever and chest pain can also co-exist. (46) Patients with asymptomatic 
of RP are often revealed by radiographic findings on plane film chest X-ray at the very late 
stage of RP. Changes appear as increased ground glass opacity and lack of clear 
demarcations of normal pulmonary structure following radiation therapy. (52) These changes 
can range from minimal i.e. slight indistinctness of pulmonary vasculature to complete 
consolidation of the irradiated area. (53) Computed tomography (CT) indications of very late 
RP are often observed post radiation therapy. CT evidence for RILI is described as: i) 
increase in density uniformly across the irradiated volume ii) patchy consolidation not 
conforming to the irradiated volume iii) discrete, non-uniform consolidation across the 
irradiated volume, and iv) solid consolidation across the irradiated volume and associated 
bronchi. (54) Figure 1-4 demonstrates two cases of RILI-CT appearance post radiation 
therapy treatment that are distinctly different in their appearance and region of occurrence. 
CT is considered more sensitive than plane film X-ray for early detection of RILI. (54-56) 
Detection of late RP by X-ray and CT is of little help, as the late detection offers no 
opportunity to modify the radiation therapy treatment plan.  
 
Figure 1-4: Left image for a) and b) show axial CT treatment planning image with contours 
conforming to radiation therapy isocenter. Corresponding right image in a) was taken 5 
months after radiation therapy and shows appearance of late RP as irregularly shaped 
consolidation, non-conformal to dose deposition curves. Right image in b) was taken 6 
months post radiation therapy and shows appearance of RP as solid homogeneous 
consolidation in the irradiated area. Figure adapted from (57). 
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1.6 Functional Imaging of Radiation-Induced Lung Injury 
Imaging modalities such as Single Photon Emission Computed Tomography (SPECT), 
Positron Emission Tomography (PET) and MRI have been used to perform imaging of RILI. 
Measures of ventilation, perfusion, relaxation times and apparent diffusion coefficients by 
these modalities can provide a sensitive measure to assess lung anatomy and function.  
1.6.1 Nuclear Medicine Imaging Methods 
Functional imaging with SPECT can provide ventilation and perfusion maps of the lung post 
injection of Technetium-99m. (58, 59) Studies have demonstrated a dose-dependent 
reduction in perfusion and ventilation at 3-4 months post radiation therapy. (60, 61) 
However, correlations between these metrics and whole lung function assessed by PFT are 
low and additional work is required to assess regional injury. (62) Additionally, SPECT 
imaging is limited in resolution, lacks specificity and provides ~3 mSv of extra whole body 
radiation dose to the patient. (63) PET imaging with Fluorodeoxyglucose (18F-FDG) has been 
performed in lung cancer patients post radiation therapy. The technique is heavily dependent 
on tissue uptake of 18F-FDG and is susceptible to a high false positive rate. (64) High uptake 
of 18F-FDG is associated with inflammation and tumour growth but no clear separation of 
cancer and RP has been demonstrated. (65) The tumour response is highly correlated to the 
detection of inflammatory change by PET. (66) As with SPECT, PET also provides 
additional radiation dose to the patient and is limited in resolution. 
1.6.2 Magnetic Resonance Imaging Methods  
MRI uses non-ionizing Radiofrequency (RF) pulses to obtain multiplanar images that are rich 
in soft-tissue contrast. Functional MRI has been used to assess lung injury post radiation 
therapy using a variety of methods. Perfusion imaging using Gadolinium-99mTc-
Diethylenetriaminepentaacetic acid (Gd-DTPA) has demonstrated consistent contrast 
enhancement in irradiated dog thorax compared to an unirradiated dog thorax. (67) 
Significant increases in relaxation times (𝑇! and 𝑇!) have also been shown in rat thorax post 
irradiation. (68) Hyperpolarized gas imaging (3He) with MRI has demonstrated changes in 
apparent diffusion coefficients in rodent lungs post radiation injury. (69) This technique has 
been applied in a clinical setting and correlation between severity of radiation injury and 
percent-ventilated volume has been quantified. (70) While functional MRI methods 
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demonstrate an improvement over the nuclear medicine imaging methods, they are still based 
on morphological and functional changes that often occur during the late phase of the injury.  
As metabolic changes precede morphological and functional changes, quantification of 
metabolic signature may help capture early onset of the disease. As such, metabolic imaging 
of early RP with hyperpolarized 13C-pyruvate may lead to early diagnosis of the disease 
using MRI. A review of basic MRI concepts that are applicable to this thesis is provided in 
the next section. 
 
1.7 Nuclear Magnetic Resonance  
The source of detectable signal in Nuclear Magnetic Resonance (NMR) is the precession of 
an ensemble average of nuclear magnetic moments in the presence of an applied static 
magnetic field. Interaction of this ensemble, or magnetization, with time-dependent 
secondary magnetic fields provides an array of information about their spatial position and 
local environment. The origin of the magnetization and its interaction with an external 
magnetic field can be described theoretically using either or both of a quantum mechanical 
approach or a classical approach. The interested reader is referred to (71, 72) for more 
details. In this section, introductory background material is provided on the origin of nuclear 
magnetization, behaviour in the presence of external magnetic fields, polarization and 
chemical shift as a theoretical basis for the thesis work described.  The basics of the MRI 
pulse sequence for Chemical Shift Imaging (CSI), gradient echo imaging and finally, the 
Dixon approach, central to the methods used in this thesis, are also described.  
1.7.1 Nuclear Magnetic Moment 
The atomic nucleus is composed of neutrons and/or protons. NMR is derived from nuclei 
consisting an odd number of neutrons and/or protons. These unpaired neutrons and/or 
protons confer a property to the nucleus know as spin (I). Spin causes the nucleus to behave 
as a spinning charge enabling the nucleus to acquire a spin angular momentum (J). The 
resulting magnetic moment is given by: 
 𝜇 =   𝛾𝐽 =   𝛾ħ𝐼, [1] 
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where 𝛾 is the gyromagnetic ratio of the nucleus under consideration, J is the spin angular 
momentum,  ħ is the reduced Planck’s constant, and I is the integer half-spin. Gyromagnetic 
ratios of the two nuclei discussed in this thesis are given in Table 1-2. 
Nucleus 𝛾 [MHz rad -1 T-1] 
1H 
13C 
267.519 
67.261 
Table 1-2: Gyromagnetic ratios for Spin ½ Nuclei described in this thesis. 
1.7.2 Magnetic Moment in the Presence of a Magnetic Field  
In the presence of a uniform external static magnetic field, 𝐵!, the magnetic moment 
experiences a torque. This torque is described by the following equation: 
 𝜏 =   𝜇  ×  𝐵!. [2] 
The principle of conservation of angular momentum requires that this torque be equivalent to 
the time derivative of the angular momentum, leading to the following equation of motion: 
 
𝑑𝑑𝑡 𝐽 =   𝜇  ×  𝐵!. [3] 
Incorporating equation [1] into equation [3] yields: 
 
𝑑𝑑𝑡 𝜇 =   𝜇  ×  γ𝐵!. [4] 
The above differential equation has a well known solution and is given by: 
 𝜇 =   𝜇!𝑒!!"# , [5] 
where 𝜔 is the Larmor frequency and is represented by the equation of motion that describes 
precession, such that: 
 𝜔 =   −𝛾𝐵!, [6] 
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The negative sign implies a clockwise direction of rotation when looking into the head of the 
vector 𝐵!. 𝜔 can be readily converted to frequency in Hz by the following expression:  
 𝜔 = 2𝜋𝑓. [7] 
Therefore, the expression for Larmor frequency in Hz is as following: 
 𝑓 =   − 𝛾2𝜋𝐵!. [8] 
 
1.7.3 Magnetization and Polarization  
In the presence of an external magnetic field, nuclei that possess spin angular momentum 
tend to align with the magnetic field. The potential energy of a magnetic moment in the 
presence of an external magnetic field is given by: 
 𝐸 =   −𝜇 ∙ 𝐵!. [9] 
The nuclei in Table 1-2 can exist in either I = + ½ spin state or I = − ½ spin state. The spin 
state of + ½ corresponds to alignment with the external magnetic field and is referred to as 
spin up, whereas the spin state of − ½ corresponds to alignment against the external magnetic 
field and is referred to as spin down. Net magnetization arises from a vector sum of spins 
aligned with the external magnetic field in a unit volume. Following equation [9], the spin 
states are separated by a net amount of energy given by: 
 Δ𝐸 =   𝛾ħ𝐵!. [10] 
Alignment of spins is approximated by the Boltzmann distribution. The ratio of nuclei with 
spin up state to nuclei with spin down state at a given temperature T is given by:  
 
𝑁↓𝑁↑ = 𝑒(!∆! !"), [11] 
where 𝑁↑ is the number of spins aligned with the magnetic field and 𝑁↓ is the number of 
spins aligned against the magnetic field. This phenomenon of spin alignment is depicted in 
Figure 1-5 that shows an aggregate of spins placed in an external magnetic field 𝐵!. The 
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excess of I = + ½ spins aligned with the external magnetic field compared to I = − ½ gives 
rise to polarization, which is defined as: 
 𝑃 =   𝑁↑ −   𝑁↓𝑁↑ +   𝑁↓. [12] 
Rearrangement of equations [10], [11], [12] provides the following expression for thermal 
polarization:  
 𝑃 =   𝑒∆! !" −   𝑒!∆! !"𝑒∆! !" +   𝑒!∆! !! = 𝑡𝑎𝑛ℎ ∆𝐸𝑘𝑇 = 𝑡𝑎𝑛ℎ ħ𝛾𝐵!2𝑘𝑇 . [13] 
Typically 2𝑘𝑇 is a much bigger quantity than ħ𝛾𝐵!, simplifying the expression for 
polarization in equation [13] to:  
 𝑃   ≅    ħ𝛾𝐵!2𝑘𝑇 . [14] 
 
 
Figure 1-5: An aggregate of spins placed in an external magnetic field. 
Magnetization can be expressed in terms of polarization in the following way: 
 𝑀 = 𝑁 ∙ 𝜇   ∙ 𝑃, [15] 
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where N is the number of magnetic dipole moments per unit volume. Combining equations 
[1], [14] and [15] leads to the following expression for the net magnetization in the presence 
of an external magnetic field 𝐵!: 
 𝑀! = 𝑁 ħ𝛾2 ħ𝛾𝐵!2𝑘𝑇 =   𝑁ħ!𝛾!𝐵!4𝑘𝑇 , [16] 
where 𝑀! refers to equilibrium magnetization.  
1.7.4 Chemical Shift  
The local magnetic field experienced by the nuclear spin is dictated by the local electron 
distribution. This leads to a phenomenon called chemical shift whereby spins in different 
chemical environments resonate at slightly different Larmor frequencies. The phenomenon of 
in vivo chemical shift is depicted in Figure 1-6, where the 13C-nuclei exhibit a different 
resonant frequency dependent upon the chemical environment of the host molecule.  
The fundamental reason for the difference in chemical shifts is the interaction of the external 
magnetic field with the variable local electron cloud distribution in the environment where 
the nuclei of interest reside. For example, protons in water molecules resonate at a different 
frequency in a tissue environment that primarily consists of muscle compared to a tissue 
environment that is primarily fat. The electron cloud arranges itself to oppose the external 
magnetic field, such that the effective magnetic field, 𝐵!! , for the local tissue environment is 
given by: 
 𝐵!! =   𝐵! 1−   𝜎 , [17] 
where 𝜎 is the shielding constant that depends on local tissue environment. Chemical shift is 
usually expressed in parts per million (ppm) of the applied magnetic field, by combining 
equation [17] with the Larmor equation as: 
 𝛿 =   𝜔! −   𝜔!𝜔!    ∙   10!, [18] 
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where 𝜔! is the Larmor frequency associated with the local tissue environment and 𝜔! is the 
predetermined reference frequency for a native frequency of 𝜔!. It should be noted that 
frequency expressed in 𝛿 is independent of the external magnetic field.  
 
 
Figure 1-6: Metabolite products of 13C-pyruvate in vivo resonate at different frequencies as 
the 13C-nuclei experience different chemical shifts due to different chemical environments. 
1.7.5 Radiofrequency Pulse 
 RF pulses manipulate the magnetization of a sample to generate the signal in NMR. RF coils 
are the electric antennae that produce these pulses. Applying a transverse RF pulse to a spin 
system results in an additional time-varying magnetic field called 𝐵!that exerts itself in a 
direction perpendicular to the main magnetic field 𝐵!. This additional magnetic field is a 
rotating vector with a frequency equal to the Larmor frequency of the nuclei under 
consideration. As 𝐵! is a rotating vector, it is convenient to transform the reference 
pyruvate 
lactate 
bicarbonate 
pyruvate-
hydrate 
alanine 
190 185 180 175 170 165 160 
Frequency (ppm) 
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coordinates from a laboratory frame to the rotating frame about z-axis (direction of 𝐵!) with 
frequency of 𝜔!. The effective magnetic field 𝐵!"" can then be described as:  
 𝐵!"" =   𝐵!𝚤 +    𝐵! −   𝜔!𝛾 𝑘 =   𝐵!𝚤. [19] 
𝐵! is applied along the x-direction and the result is tipping of the net magnetization to y-
direction of the rotating frame of reference. The purpose of 𝐵! is to tip, or nutate, the net 
magnetization by a flip angle 𝛼, represented as: 
 𝛼 =   𝛾 𝐵! 𝑡    ∙ 𝑑𝑡!! , [20] 
where 𝑡 denotes the duration of 𝐵!. Following equation [4], once the aggregate of spins is 
perturbed from the direction of the static magnetic field of 𝐵!, the macroscopic behaviour 
can be represented by the following equation:  
 𝑑𝑑𝑡𝑀 =   𝑀  ×  γ𝐵!"" =   𝑀  ×  γ𝐵!𝚤. [21] 
If a flip angle of 𝛼 =   𝜋/2 is used for 𝐵!, the net magnetization completely aligns in the y-
direction. A static frame of reference, rotating frame of reference and the process of tipping 
magnetization, referred to as the excitation pulse are shown in Figure 1-7.  
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Figure 1-7: The lab frame (x, y, z) and the rotating frame (x’, y’, z’). After the 
transformation, application of a RF pulse (𝜶 =   𝝅/𝟐) in the x’-axis will lead to tipping of net 
magnetization in the y’-axis.  
After the excitation RF pulse with a flip angle of 𝛼, the net magnetization slowly returns to 
equilibrium i.e. re-aligns with 𝐵!. This process of relaxation is called longitudinal relaxation 
or spin-lattice relaxation.   
1.7.6 Longitudinal and Transverse Relaxation  
Spin-lattice relaxation occurs as the excited magnetic dipoles return to equilibrium by 
interacting with the surrounding lattice. Spin-lattice relaxation is described using an 
exponential time decay constant 𝑇!, called the longitudinal or the spin-lattice relaxation time. 
The time dependence of the longitudinal component of magnetization, 𝑀! in the presence of 
longitudinal relaxation is expressed by the following differential equation: 
 
𝑑𝑀!𝑑𝑡 =   −   𝑀! −   𝑀!𝑇! , [22] 
where 𝑀!is the equilibrium magnetization and 𝑇! is the longitudinal relaxation time constant. 
The general solution for equation [22] is: 
 𝑀! 𝑡 = 𝑀 0 𝑒!! !! +   𝑀!   1−   𝑒!! !! , [23] 
where 𝑀 0  is the longitudinal magnetization at zero time. For an excitation RF pulse of 𝛼 =   𝜋 2, 𝑀 0 = 0 and the second component of equation [23], 𝑀!   1−   𝑒!! !!  dictates 
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the re-growth of magnetization to thermal equilibrium such that the magnetization re-grows 
to ~63% of the thermal equilibrium in one 𝑇!. 
Relaxation transverse to 𝐵! or spin-spin relaxation occurs due to local alteration in magnetic 
fields that the spins experience relative to neighbouring spins. Slight variance in the 
environment of the spins leads to different local magnetic fields. The dipolar interaction 
between these spins causes a dephasing of the transverse magnetization and a broadening of 
the resonant frequency. This relaxation is described by an exponential time decay constant 𝑇!, called the transverse relaxation or the spin-spin relaxation time constant. This 
phenomenon is described by the following differential equation: 
 
𝑑𝑀!"𝑑𝑡 =   −𝑀!"𝑇! , [24] 
where 𝑀!" is the magnetization in transverse plane. The general solution for equation [24] 
results in: 
 𝑀!" 𝑡 = 𝑀 0 𝑒!! !! , [25] 
where 𝑀 0  is the transverse magnetization immediately following an excitation RF pulse. 
Another transverse relaxation time constant called the apparent transverse relaxation time, 𝑇!∗, is shorter than 𝑇!, due to additional components that cause dephasing of the transverse 
magnetization. Some of these components include: static 𝐵! inhomogeneities, magnetic 
susceptibility differences, chemical exchange, diffusion and chemical shift. Exponential time 
decay with transverse relaxation time constant 𝑇!∗ results in a Free Induction Decay (FID). 
The Fourier transform of a FID is a Lorenzian shape where the width of the peak is 
dependent on the 𝑇!∗ of the FID. This is shown in Figure 1-8. 
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Figure 1-8: Top left shows a FID with an apparent transverse relaxation time constant, 𝑻𝟐∗ . 
Top right shows a Lorentzian peak, which is the Fourier transform of the FID. Full-width at 
Half Maximum (FWHM) of the Lorentzian peak is related to 𝑻𝟐∗  such that a longer 𝑻𝟐∗  results 
in a lower FWHM for the Lorentzian peak.  
 
1.7.7 MR Signal and RF Coils  
The Bloch equation describes the time evolution of magnetization in the rotating frame of 
reference, in the presence of an external static magnetic field (𝐵!), a time varying magnetic 
field (𝐵!) and associated longitudinal and transverse relaxation. The magnetization varies 
with time as: 
 𝑑𝑀𝑑𝑡 =   𝛾𝑀  ×  𝐵 −   𝑀!𝑥 +   𝑀!𝑦𝑇!∗ −    𝑀! −   𝑀! 𝑧𝑇! , [26] 
where 𝑇! and 𝑇!∗ are the longitudinal and apparent transverse relaxation time constants 
respectively.  
A RF coil is used to transmit the time-varying magnetic field and/or receive the voltage 
generated by the sample. Based on Faraday’s law of electromagnetic induction, the time 
varying magnetization generates a corresponding electromotive force or voltage in the RF 
coil. Since 𝐵! is produced by the RF coil; based on the principle of reciprocity, the sensitivity 
of a coil can be measured by the transverse field that the coil produces upon application of 𝐵! 
per unit amount of current produced by the coil. The induced voltage can be expressed as: 
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 𝑉 𝑡 =    𝑑𝑑𝑡 𝑑𝑉   ∙    𝐵! 𝑟 !"    ∙   𝑀!" 𝑟, 𝑡   ,!!!  [27] 
where 𝑉! represents the volume of the sample over which the integral is calculated. The final 
voltage obtained contains the Larmor frequency of all the chemical species present in the 
sample and varies as a function of time as it is modulated by the relaxation mechanisms 
previously discussed. The final signal obtained is the FID, and is represented as:  
 𝑆 𝑡 = 𝐴𝜔! 𝑑𝑉   ∙  !!! 𝐵! 𝑟 !"    ∙   𝑀!",! 𝑟    ∙ 𝑒!! !!∗    ∙   𝑒!!∆!" , [28] 
where A is a constant that depends on coil filling, coil geometry, gain and frequency 
response of the receiver. ∆𝜔 is the range of Larmor frequencies detected by the RF coil and 
depends on the bandwidth of the RF receive coil and the magnetic gradients applied for 
spatial encoding.  
A RF coil primarily consists of electrical resonant circuits and is used to transmit the time-
varying magnetic field 𝐵!and/or receive the voltage 𝑉, generated by the spin system. The 
geometry of RF coils is carefully chosen to maximize the Signal-to-Noise-Ratio (SNR) and 
produce good quality images. The frequency of the electrical resonant circuit of a coil is 
tuned very closely to the Larmor frequency of interest. This enables the coil to provide 
efficient transmission of 𝐵!and sensitive reception of 𝑉 from the spin system. The resonance 
behaviour of the coil can be approximated by a combination of its inductance and 
capacitance in the following manner:  
 𝜔 =    1𝐿𝐶  , [29] 
where L is the total inductance of the RF coil and C is the total capacitance of the RF coil 
respectively. A volumetric (distributed capacitance) design of coils generally known as a 
birdcage is regarded as the best for 𝐵! homogeneity at clinical magnetic field strengths (< 
3T). Birdcage coils are versatile and are often used for both transmit and receive operation. 
The distance between the sample and coil is an important consideration for sensitivity of the 
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coil. As shown in equation [28], the MRI signal is dependent on the integral over the volume 
present in the RF coil. In general, the coil sensitivity is inversely proportional to the distance 
between the coil elements and the sample. This property enables surface coils to attain a 
higher sensitivity in general as they can be placed fairly close to the sample. The shortcoming 
of surface coils is the non-uniform transmission of 𝐵!. Advantages of a birdcage design 
(uniform transmission of 𝐵!) and a surface coil (higher sensitivity) can be combined to form 
a Transmit-Only/Receive-Only (TORO) system that offers the best SNR. In this system, the 
larger birdcage coil is used to provide very uniform 𝐵! field only and a highly sensitive 
surface coil is used for reception of signal only. As a part of the research for this thesis, a 
TORO system was developed for in vivo 13C-MRI. Details on design, construction and 
operation can be found in the Appendix A-1. It is the highly sensitive TORO system that 
enabled spatial disease characterization in Chapter 3.  
1.7.8 Spatial Localization of Spins  
The signal received from the spins must be spatially localized in order to form an image. 
Spatial localization of the spins is performed by the use of gradient magnetic fields in 
addition to 𝐵!. Gradients can be applied in all three directions such that the net magnetic 
field is represented as: 
 𝐵 𝑥,𝑦, 𝑧 = 𝐵!𝑘 +    𝐺!𝑥 +   𝐺!𝑦 +   𝐺!𝑧   𝑘, [30] 
where 𝐺! =    !!!!"    ,𝐺! =    !!!!"   𝑎𝑛𝑑  𝐺! =    !!!!"    . The combined field points in the z-direction 
with variations in x, y, and z direction for spatial localization. The application of gradients 
leads to additional accumulation of phase, which is typically represented in the following 
way:  
 𝑘 =    𝛾2𝜋 𝑑𝑡!    ∙   𝐺 𝑡!!! , [31] 
where 𝐺 𝑡!  is the time varying gradient magnetic field that is turned on for a time 𝑡. 
Application of a gradient magnetic field and resulting accumulation of phase is represented 
by the position of a vector in k-space, 𝑘. k-space is a convenient method to represent the 
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acquired MRI data and contains spatial frequency components obtained by Fourier transform 
of the effective spin density.  
A slice select gradient is used to spatially localize a 2D slab of the sample. The slice select 
gradient is turned on simultaneously along with a RF pulse. An axial slice is excited with the 
thickness ∆𝑧, which is defined by: 
 ∆𝑧 =    𝐵𝑊!"𝛾2𝜋 𝐺! , [32] 
where 𝐵𝑊!" is the bandwidth of the corresponding RF pulse and 𝐺! is the strength of the 
slice-select gradient (conventionally assumed to be in the direction of the magnet bore). 
Phase is accumulated during the time the slice-select gradient is turned on, and an additional 
gradient is applied in the opposite direction after slice-select gradient to rewind the 
accumulated phase. This is demonstrated by 𝐺! in Figure 1-9. 
Further spatial localization in the 2D slab can be attained using frequency- and phase-encode 
gradients that can be applied along 𝐺!  𝑎𝑛𝑑  𝐺! after the slice-select gradient. Phase-encode 
gradients are used to encode columns within the 2D slab selected by the slice-select gradient, 
as shown in Figure 1-9. The phase-encoding gradient, when applied to a system of spins, 
enables the accumulation of phase. When the gradient is turned on, it changes the main 
magnetic field slightly which leads to a slight change in the precession frequency of the 
spins, and that frequency is a known linear function of spatial position.  When the gradient is 
turned off, the spins return to the original precession frequency but retain the phase 
accumulated during the gradient. Variable amounts of phase encoding are applied after each 
consecutive RF pulse to encode voxels in the axial slab to a unique position in the k-space. 
The acquired signal from each voxel is sampled as a FID and is represented by one point in 
k-space. The Field of View (FOV) in the direction that phase-encode gradient is applied is 
given by:  
 𝐹𝑂𝑉! =    1𝛾2𝜋 ∆𝐺!    ∙   𝜏!" , [33] 
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where ∆𝐺! is the phase-encode gradient step in either 𝐺! or 𝐺! direction that is turned on for 
a time 𝜏!".  
The frequency-encode gradient is applied along 𝐺! or 𝐺! to encode the spatial localization of 
spins. It is typically applied during signal read-out along just one direction to encode 
columns within the selected 2D slab. Use of phase encoding and frequency encoding 
gradients in a mutually orthogonal direction within the 2D selected slab leads to spatial 
encoding of the voxels. The FOV in the frequency-encode direction is given by: 
 𝐹𝑂𝑉! =    1𝛾2𝜋 𝐺!    ∙   𝜏! , [34] 
where, 𝐺! is the amplitude of frequency-encode gradient applied for a time 𝜏!. Formation of 
the MRI image with the use of gradient magnetic fields is described in the next section. 
Figure 1-9 also shows a pulse sequence-timing diagram that provides a visual representation 
of the order of gradients during a gradient echo sequence. 
1.7.9 Gradient Echo Imaging  
2D gradient echo imaging is a basic MRI pulse sequence used to form an MRI image. 
Gradient echo imaging starts with a RF pulse turned on simultaneously along with the slice-
select gradient to select a 2D slab within a 3D volume as shown in Figure 1-9. The slice-
select gradient is applied along 𝐺! such that the thickness of the selected 2D slab is given by 
equation [32]. Next, a phase-encode gradient is turned on along 𝐺! following the slice select 
gradient. This enables phase accumulation for a column in the selected 2D slab. Following 
phase encoding, a frequency-encode gradient is turned on along 𝐺!. A pre-phase gradient 
with negative amplitude is turned on at the same time as the phase-encode gradient. A 
readout gradient is turned on following the pre-phase gradient during which the data is 
acquired. The read-out gradient has twice the area of the pre-phase gradient so that the 
gradient echo occurs at the center of the readout gradient. This phenomenon along with the 
full pulse sequence is shown in Figure 1-9. The time between RF pulse and the center of 
readout gradient is called the Echo Time (TE). The time for repetition of the pulse sequence 
is called the Repetition Time (TR).  
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Figure 1-9: Pulse sequence diagram for gradient echo imaging (left) and corresponding 
sample k-space trajectory (right).  
1.7.10 Chemical Shift Imaging  
Chemical Shift Imaging (CSI) is also known as Magnetic Resonance Spectroscopic Imaging 
(MRSI) as it enables the acquisition of spectra spatially localized to a volume element, or 
voxel. It uses phase encoding gradients only to encode the voxels in order to preserve the 
chemical shift of the constituent chemical species. Spectra from each voxel contain the 
information about chemical shift of an array of metabolites and their relative magnitude 
within that voxel. A pulse sequence for 2D-MRSI begins with the application of an excitation 
RF pulse and a slice-selective gradient 𝐺! simultaneously. Following the excitation RF pulse 
and slice-selective gradient, phase-encoding gradients are applied in the other two 
dimensions to encode voxels within the plane of the selected axial slab. Assuming both 
phase-encode gradients are turned on for a time 𝜏 with different amplitudes 𝐺! and 𝐺! as 
shown in Figure 1-10, the position in k-space is represented as following: 
 𝑘!! = 𝑎! !!! 𝐺!    ∙   𝜏 , and 𝑘!! = 𝑎! !!! 𝐺!    ∙   𝜏 , [35] 
where 𝑎! is the amplitude of phase-encode gradients used for each encoding step. The total 
number of points in each direction in k-space determines the resolution of 2D-MRSI for a 
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given FOV.  The FOV in the x- and y-direction is also a function of phase-encode gradient 
step and the time that it is turned on for 𝜏, such that: 
 𝐹𝑂𝑉! =    1𝛾2𝜋 ∆𝐺!    ∙   𝜏   , and  𝐹𝑂𝑉! =    1𝛾2𝜋 ∆𝐺!    ∙   𝜏, [36] 
where ∆𝐺! and ∆𝐺! are the x- and y-direction phase-encode gradient steps respectively. Once 
k-space is fully acquired, a 2D inverse Fourier transform is performed on the k-space data to 
reveal the MRSI data.  
 
Figure 1-10: Pulse sequence for 2D-MRSI and corresponding k-space filling are shown. The 
RF pulse and the slice select gradient are played out simultaneously and lead to the selection 
of an axial slab.  Phase-encode gradients are applied to encode all voxels, one by one in the 
selected slab. k-space is organized such that each point in k-space represents a FID. Adapted 
from reference (73). 
1.7.11 Dixon Approach to Image Chemical Species with a Sparse 
Spectrum  
The Dixon approach has been used extensively to image chemical species with a sparse 
spectra. It is usually based on a gradient echo type of pulse sequence where the 
reconstruction to formulate final images relies on known chemical shifts between the 
chemical species. Gradient echo based pulse sequences generally read-out an entire k-space 
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line after the excitation RF pulse compared to one k-space point in CSI and as a result are 
significantly faster. The echo times in the gradient echo sequence are selected such that the 
chemical species with known chemical shifts appear in-phase or out-of-phase with respect to 
each other. The Dixon approach was first used to separate water and fat that resonate 3.5 ppm 
apart in proton MRI. A two point Dixon approach to separate water and fat is demonstrated 
by Figure 1-11. The transverse magnetization of water and fat behave differently due to the 
difference in their chemical shifts. The net magnetization of fat goes in and out of phase 
when the frequency of the rotating frame of reference is fixed at the resonant frequency of 
water. Proper selection of echo times ‘a’ and ‘b’ provide a net image at ‘a’, which is the sum 
of in-phase water and in-phase fat. Similarly, the total image at ‘b’ is the sum of in-phase 
water and out-of-phase fat signals. The images at ‘a’ and ‘b’ are added together in a complex 
fashion to yield a pure water image and subtracted in a complex fashion to yield a pure fat 
image. (74)  
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Figure 1-11: Imaging at echo times ‘a’ and ‘b’ results in a net image of in-phase water and 
in-phase fat at ‘a’ and in-phase water and out-of-phase fat at ‘b’ respectively. These images 
when added and subtracted together provide a pure water and fat image. Adapted partially 
from reference (74). 
Three echoes can be collected using the Dixon approach to correct for 𝐵! inhomogeneities in 
addition to separation of water and fat phases. (75) This helps with the reduction of error 
associated with accurate quantification of the chemical species in a non-uniform 𝐵! field 
map. The Dixon approach of Iterative decomposition of water and fat with echo asymmetry 
and least squares estimation (IDEAL) has been used extensively to separate water and fat 
images, (76) and can be based on a gradient echo pulse sequence approach. (77) It improves 
upon the traditional Dixon approach by incorporating a parameter called number of signals 
averaged. This parameter can be optimized by the choice of echo times, which optimizes the 
overall SNR and quantification of chemical species. (78) 
The IDEAL technique has been used with hyperpolarized 13C-pyruvate to separate pyruvate 
and the downstream metabolites. (79) A novel application of the IDEAL technique used to 
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separate 13C-bicarbonate and 13C-carbon dioxide images to construct a ratio metric pH map is 
presented in Chapter 3.  
 
1.8 Hyperpolarized 13C-pyruvate Magnetic Resonance 
Metabolic Imaging 
MRI signal is dependent on the net magnetization that aligns with the external magnetic 
field. The magnetization in turn is proportional to the polarization as described in equation 
[16]. Typically, with an external magnetic field of 3T, using equation [14], the thermal 
polarization of protons is 10 ppm or 0.001 %. Clinical MRI has been very successful at 
anatomical imaging as the poor polarization is compensated by the high concentration of 
protons in vivo. Other nuclei with spin =1/2 (3He, 129Xe, 13C) can be used with MRI but 
typically the polarization and the concentration are the limiting factors. For example: 13C has 
a natural abundance of only 1.1 % and a gyromagnetic ratio of ¼ compared to protons (Table 
1-2) significantly limiting SNR. Improvement in polarization methods has led to the 
emerging field of hyperpolarized-MRI. Hyperpolarized Noble Gas (HNG) MRI for lung 
imaging uses 129Xe and 3He that are polarized 4-5 orders of magnitude greater than the 
corresponding thermal equilibrium. (80) Spin exchange optical pumping is typically used for 
polarization of HNG. (81) Imaging metabolism coupled to a particular enzyme-catalyzed 
reaction in vivo has been made possible with hyperpolarized 13C-MRI. (1) The 
hyperpolarization of 13C-substrates can be attained either by para-hydrogen induced 
polarization process (82) or Dynamic Nuclear Polarization (DNP) process. (83) DNP is the 
more frequently used method and has been used to polarize both 13C-substrates (13C-pyruvate 
and 13C-bicarbonate) used for 13C-MRI in Chapters 2, 3 and 4.  
1.8.1 Dynamic Nuclear Polarization Method 
DNP is based on polarization of nuclear spins in the solid state. Unpaired electrons are 
required as one of the ingredients to assist with the process. Overhauser first discovered this 
phenomenon where highly polarized unpaired electrons under the influence of a microwave 
irradiation source transfer their polarization to the nuclear spins. (84) The phenomenon came 
to be known as the Overhauser effect. The interested reader is referred to (85-87) for the 
exact theory on the quantum mechanical interaction between the electrons and nuclei under 
 31 
 
the influence of a microwave irradiation source. The physical conditions best suited for 
achieving high polarization are low sample temperature, high magnetic field around the 
sample and irradiation with a microwave source. The sample is prepared as a mixture of 
unpaired electrons, glycerol and the 13C-substrate. A homogeneous distribution of electrons 
is one of the most important considerations for the sample preparation. The source of 
unpaired electrons is typically an organic free radical. Glycerol is added as a glassing agent 
to achieve homogeneous distribution of unpaired electrons and to obtain an amorphous solid 
after cooling the sample. For in vitro and in vivo use, after polarization in the solid state at 
low temperature, the sample is quickly brought into a liquid state at room temperature. (83) 
The commercial DNP system (Hypersense, Oxford Instruments, UK) used for research 
presented in this thesis polarizes 13C-substrates at very low temperature (1.4 Κ), high 
magnetic field (3.35 T) and in the presence of microwave irradiation (~94 GHz). This 
process is depicted in Figure 1-12. The specific recipes for 13C-pyruvate and 13C-bicarbonate 
preparation and polarization are discussed in Chapters 2 and 3.  
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Figure 1-12: Illustration above shows homogeneous distribution of electrons within the 13C-
nuclei for efficient polarization. The amorphous solid is irradiated with a microwave source 
(as shown by arrows ~94 GHz) at high magnetic field and low temperature to achieve desired 
polarization.  
1.8.2 Metabolism of Hyperpolarized 13C-pyruvate  
13C-pyruvate is used as a probe to image the metabolism of the endogenous pyruvate. It is 
quite suitable as it offers a high degree of polarization, good water-solubility and a 
sufficiently long relaxation time in vivo. Hyperpolarized 13C-pyvuate has been used 
extensively to study pre-clinical cancer models. It has also demonstrated useful results in 
phase I clinical trials in an application towards prostate cancer in humans. (2) In vivo 
metabolism of intravenously injected hyperpolarized 13C-pyruvate is demonstrated by Figure 
1-13. Injected 13C-pyruvate is shuttled past the cell membrane and arrives at the intersection 
of three major metabolic pathways. In healthy cells, most of the pyruvate, which is derived 
from glucose, is shuttled to the mitochondria where it produces energy by aerobic respiration. 
Under hypoxic/ischemic conditions, cells switch over to anaerobic respiration where Lactate 
Dehydrogenase (LDH) readily converts pyruvate to lactate. Pyruvate also undergoes 
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transamination to form alanine, catalyzed by Alanine Transaminase (ALT) in the cytoplasm. 
13C-pyruvate that is shuttled into mitochondria also leads to irreversible production of 13C-
carbon dioxide, which readily equilibrates with 13C-bicarbonate, catalyzed by Carbonic 
Anhydrase (CA).  
Imaging endogenous enzyme catalyzed pyruvate to lactate conversion with the use of 
hyperpolarized 13C-pyruvate provides insight into the level of anaerobic respiration. The total 
MRI signal for 13C-pyruvate and the by-product 13C-lactate depends on initial polarization, 
concentration and amount of 13C-pyruvate injected, in vivo relaxation (13C-pyruvate, 13C-
lactate) and pool size of endogenous pyruvate and lactate. To quantify the LDH enzymatic 
reaction, 13C-Lactate to 13C-Pyruvate Signal Ratio (Lac/Pyr) is derived where the total lactate 
signal to total pyruvate signal is normalized. This factor provides a reliable quantification of 
the anaerobic metabolism and has been used in Chapters 2 and 4 to capture early RP 
metabolism in RILI rat model.  
 The conversion between 13C-carbon dioxide and 13C-bicarbonate is highly dependent on pH 
as bicarbonate is the largest extracellular buffer in vivo. 13C-bicarbonate can also be polarized 
by DNP and administered intravenously. As a result, imaging of 13C-carbon dioxide and 13C-
bicarbonate can provide insight into the pH of the immediate extracellular environment. This 
concept formed the basis for Chapter 3 in which, a novel pH imaging approach based on the 
Dixon method is discussed in detail.  
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Figure 1-13: Injected hyperpolarized 13C-pyruvate results in 13C-lactate, 13C-alanine, 13C-
carbon dioxide and 13C-bicarbonate. Up-regulation of anaerobic respiration in hypoxic tissue 
environment leads to a higher production of lactate that can be quantified by the factor, 
lac/pyr.  
1.8.3 Data Acquisition Considerations for Hyperpolarized 13C-MRI 
The net detectable signal from administered 13C-substrates and the subsequent by-products 
are a function of their longitudinal relaxation times, concentration and initial polarization of 
the injected 13C-substrate. As the polarization in the parent molecule and its metabolites 
decays fast due to short T1 relaxation times (e.g. 13C-pyruvate ~40 s in vivo), imaging time is 
one of the primary constraints for 13C-MRI. Typically, the CSI sequence used to acquire data 
for research presented in this thesis took ~12 s after a wait time of 25 seconds from the start 
of intravenous injection of 13C-pyruvate. The wait time is sufficient to allow 13C-pyruvate to 
clear out from the vasculature as it is absorbed by the cells and converted into 13C-lactate. A 
secondary consideration for pulse sequences is the number of RF pulses used to acquire each 
dataset. A minimal number of RF pulses is preferred as each RF pulse causes a loss of 
unrecoverable polarization. The relative amplitude of each RF pulse is also calibrated 
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carefully as the amount of polarization lost also depends on the flip angle that each RF pulse 
generated. For example, the in vivo acquisition of CSI dataset in this thesis used 144 RF 
pulses with a 10-degree flip angle for each RF pulse.  
 
1.9 Thesis Hypothesis and Objectives 
The objective of this thesis was to investigate metabolic changes occurring in rat lungs 
during RP. As metabolic changes precede morphological and functional changes, assessment 
of metabolic profile could help in early diagnosis of RILI. Hyperpolarized 13C-MRI with its 
ability to polarize variety of 13C-substrates was used to quantify metabolism during RP. 13C-
substrates of 13C-pyruvate and 13C-bicarbonate were used to study enzyme-catalyzed 
reactions. We hypothesize that hyperpolarized 13C-MRI can be used to detect metabolic 
changes in early RP which correlate with the known histological transformations. The sub-
objectives established for this purpose are included as part of the manuscripts and 
Appendices that follow.  
This chapter has described the motivation for the study of unintended lung injury caused by 
therapeutic radiation of the lung cancer. An overview of lung cancer, radiation therapy and 
the pathophysiology of RILI have been described. Clinical diagnosis and emerging imaging 
modalities for detection of RILI have also been discussed. MRI physics of pulse sequences 
used for the research in this thesis such as Chemical Shift Imaging, gradient echo imaging 
and the IDEAL method were explained. Introduction to the DNP process used for 
polarization of 13C-substrate and the use of 13C-pyruvate and 13C-bicarbonate to probe 
particular metabolic pathways was described in a biological context.  
Chapter 2 describes the validation of detection of metabolic signature in early RP using 
hyperpolarized 13C-pyruvate. Six rats were irradiated in the entire thorax region with a 
cobalt-60 source (dose of 14 Gy, 1 fraction) and imaged two weeks later along with healthy 
age-matched controls. Results were analyzed for change in lac/pyr in the irradiated cohort 
compared to the healthy cohort and histology was used as a confirmation for the presence of 
injury. Kundan Thind was responsible for construction of a 13C-birdcage coil and a 1H-
surface coil in addition to the experimental design, testing of protocols, animal preparations, 
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experimental data acquisition and analysis. Dr. Alexei Ouriadov provided assistance in 
optimization of the RF coils and the pulse sequences. Dr. Eugene Wong and Dr. Matthew 
Fox assisted with the irradiation procedure. Dr. Lanette Friesen-Waldner assisted with the 
animal preparation and in polarization of the 13C-pyruvate. Dr. Albert Chen was pivotal in 
providing numerous discussions and the technical guidance for the study. Dr. Eugene Wong 
and Dr. Jake Van Dyk provided meaningful discussion about the work. Dr. Giles Santyr 
provided overall guidance for the project and assistance with the manuscript presentation. 
This work has been published in Magnetic Resonance in Medicine. (DOI: 
10.1002/mrm.24525) 
Chapter 3 expands on the findings in Chapter 2. The objective for this Chapter was to capture 
metabolic profile in early RP in a regional and longitudinal manner and correlate the changes 
to histology. To capture regional metabolic changes, MRI hardware was improved by 
construction of a TORO coil system that enabled an increase in SNR of 3-4x over the 
transmit-receive RF coil configuration. This has been described in Appendix A-1. Twelve 
rats were irradiated in a conformal manner to the right lung using a micro-CT system. 13C-
data was collected at day 5, 10, 15 and 25 post irradiation from three irradiated and three 
healthy age-matched control animals. Macrophage count from the histology of rat lungs was 
obtained and correlated with changes in lac/pyr. Kundan Thind was responsible for 
construction of the 13C-TORO coil system (Appendix A-1) in addition to the experimental 
design, experimental data acquisition and analysis. Michael Jensen assisted with the 
irradiation procedure using micro-CT. Dr. Francisco Martinez and Dr. Tim Scholl assisted in 
the polarization of 13C-pyruvate for the experiments. Elaine Hegarty performed the animal 
preparation pre-MRI and obtained histology post-MRI. Dr. Albert Chen was pivotal in 
providing numerous discussions and the technical guidance for the study. Dr. Eugene Wong 
and Dr. Jake Van Dyk provided meaningful discussion about the work. Dr. Giles Santyr 
provided overall guidance for the project and assistance with the manuscript presentation. 
This work has been submitted to the journal of Radiotherapy and Oncology. (August 2013: 
RO-D-13-00907) 
Chapter 4 describes a novel method to map pH using hyperpolarized 13C-bicarbonate with 
the IDEAL pulse sequence. Maintenance of pH balance is one of the most essential 
homeostatic processes in vivo, disruption of which could lead to severe adverse affects. The 
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disruption could be caused by onset of cancer, metabolic and respiratory acidosis and 
alkalosis. In particular, onset of severe RILI could lead to hypoxic tissue environment that 
would result in a build-up of lactic acid. Accumulation of lactic acid in the tissue results in an 
acidic tissue environment. Non-invasive pH mapping could potentially help with diagnosis of 
RILI and other diseases that result in pH imbalance. The IDEAL pulse sequence was used to 
map 13C-bicarbonate and its downstream metabolite of 13C-carbon dioxide. These form an 
acid-base pair and the ratio of 13C-bicarbonate to 13C-carbon dioxide aids in the construction 
of the pH map. Kundan Thind was responsible for construction of the phantoms, 
experimental design, experimental data acquisition and analysis. Dr. Francisco Martinez and 
Dr. Tim Scholl assisted in the polarization of 13C-bicarbonate for the experiments. Curtis 
Weins provided assistance with the IDEAL pulse sequence. Dr. Albert Chen was pivotal in 
providing numerous discussions and the technical guidance for the study. Dr. Giles Santyr 
provided overall guidance for the project and assistance with the manuscript presentation. 
This work will be submitted to the journal of Magnetic Resonance in Medicine.  
Chapter 5 discusses the results from the three preceding manuscripts and their contribution 
towards metabolic imaging in the lung for early diagnosis of RP. The discussion includes the 
merits of early assessment, shortcomings of the studies and future work.  
The Appendix A-1 provides additional detail on the design and construction of the TORO 
coil system and appendix A-2 provides details on statistical tests used in the thesis.  
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Chapter 2: Detection of Radiation-induced Lung Injury 
using Hyperpolarized 13C Magnetic Resonance 
Spectroscopy and Imaging  
 
K. Thind, A. Chen, L. Friesen-Waldner, A. Ouriadov, T. J. Scholl, M. Fox, E. Wong, J.Van 
Dyk, A. Hope, and G. Santyr 
Magnetic Resonance in Medicine. September 2012. DOI: 10.1002/mrm.24525 
2.1. Introduction  
Lung cancer was the most commonly diagnosed cancer in males in 2008 globally, and fourth 
most commonly diagnosed cancer in females. It was also responsible for the largest number 
of cancer related deaths in 2008. (1) Radiation therapy is as an important treatment method 
for lung cancer, (2) but can lead to RILI, as the lung is an extremely radiosensitive organ. (3) 
RILI begins with inflammation of the lung referred to as RP, which is the most common 
dose-limiting factor for thoracic radiation therapy and develops in as many as 37% of 
patients receiving radiation for lung cancer. (2, 4, 5) Anatomical and functional changes 
associated with RILI include capillary damage, obstruction of airways and thickening of the 
septa, resulting in ventilation-perfusion mismatch. RILI can present with shortness of breath, 
cough, or fever and may require oxygen therapy, ventilator support or even cause death in 
extreme cases. (6) If changes associated with RILI could be detected, a given radiation 
therapy plan could potentially be altered to reduce adverse effects. Furthermore, medical 
intervention in patients developing RP maybe be possible if the injury process can be 
detected at an early stage. (7)  
At the cellular level, immunohistochemical analysis of the irradiated lung reveals 
macrophage infiltration and activation of inflammatory cytokines. (8, 9) It has also been 
shown that lung hypoxia is an important contributing factor in the mediation of the 
inflammatory process and onset of the RP phase of RILI. (10) Decreased paO2 has also been 
reported following irradiation (11, 12), an indicator of hypoxia. (13)  
 46 
 
CT is currently the most common modality used to detect RILI in the clinic. CT can measure 
lung tissue density changes associated with late-stage RILI, but provides no functional 
information. (9) Technetium-99m SPECT can provide regional ventilation and perfusion 
changes with the onset of RILI but lacks specificity. (14) Dynamic contrast-enhanced MRI 
with Gd-DTPA has been used to detect changes post-irradiation in dog lungs. (15) MRI has 
also been able to measure significant changes in relaxation times (T1 and T2) post-irradiation 
in rodent lungs. (16) Hyperpolarized 3He MRI has also been able to detect significant 
changes in the Apparent Diffusion Coefficient (ADC) values in rodent lungs post irradiation. 
(17) These imaging techniques show improvement over global paO2 measurements but are 
primarily based on late-stage morphological and functional changes (e.g., fibrosis). Imaging 
biomarkers sensitive to early metabolic changes associated with RP (e.g., inflammation and 
hypoxia) at the cellular level could provide an approach for earlier detection and treatment of 
RILI.  
Recent advances in technology have enabled increases in the MRI signal from 13C-enriched 
substrates by a factor of more than 105 using the DNP and dissolution method. Moreover, the 
signal intensity is enhanced for both the initially hyperpolarized substrate as well as many of 
its metabolic products. (18-20) Specifically, pyruvate enriched to 13C at the C-1 position of 
the molecule, can be hyperpolarized to a high via DNP and has sufficiently long T1 for 
subsequent imaging in vivo. This enhanced polarization provides sufficient signal for high 
spatial and temporal resolution imaging of pyruvate and its metabolic products. (21-24) 
Several studies have demonstrated hyperpolarized 13C to be useful for studying changes in 
metabolic exchange/conversion of pyruvate to lactate, alanine and bicarbonate in vivo. (25-
30) The feasibility of using hyperpolarized [1-13C] pyruvate and lactate signals to measure 
metabolic changes associated with lung ischemia has been shown ex vivo. (31) Measuring 
changes in hyperpolarized [1-13C] pyruvate and lactate signals may be a useful approach for 
non-invasive detection of RILI at an early stage in vivo. Specifically, hypoxia during RP is 
expected to increase the level of anaerobic respiration to meet the constant energy needs of 
the tissue, which in turns leads to a higher level of lactate. We hypothesize that lactate-to-
pyruvate signal ratio in the lung as measured by hyperpolarized 13C Magnetic Resonance 
Spectroscopy (MRS) and MRSI will increase following thoracic irradiation due to the onset 
of hypoxia and up-regulation of anaerobic respiration and will correlate with a decrease in 
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paO2.  
In this study, lactate-to-pyruvate signal ratios were measured using hyperpolarized 13C 
spectroscopy and imaging in rats two weeks post whole-thorax irradiation (n = 6) and 
compared to lactate-to-pyruvate signal ratios obtained from healthy, age-matched rats (n  = 
6). RILI induced inflammation and hypoxia were confirmed using microscopy of 
bronchoalveolar lavage (BAL) specimens and by measurement of paO2 using blood sampling 
respectively. Dynamic spectroscopy was first performed over the entire thorax and kidney 
region to reveal the time course and total pyruvate and lactate levels. 2D-CSI was then 
performed at the optimal time window to quantify regional pyruvate and lactate signal 
intensities specifically in the heart and in the lung.  
 
2.2. Methods 
2.2.1 Animal Irradiations 
All procedures followed animal care protocols approved by the University of Western 
Ontario (ACVS) and were consistent with procedures approved by the Canadian Council on 
Animal Care (CCAC). To induce RILI, Sprague Dawley rats (weight = 350 ± 50 g) were 
irradiated with a dose of 14 Gy delivered uniformly using a 60Co source at the London 
Regional Cancer Program center. A 4 cm diameter collimator was used to deliver the 
radiation to the entire thorax.  Animals were anesthetized using isoflurane delivered with a 
nose cone and were secured in a polyvinyl box that served as a build up layer for the 60Co 
beam. The setup is shown in Figure 2-1. 
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Figure 2-1: a) Photograph 60Co irradiator with animal positioning system and the isoflurane 
vaporizer. b) Irradiator seen from top view showing custom-built animal holding box and the 
lead collimator with an opening of 4 cm. 
A pilot study involving eight separate rats irradiated with either 12 or 18 Gy was used to 
assess the appropriate whole lung radiation dose to be used in the final cohort study. A single 
fractionation of 14 Gy was chosen as a compromise in order to induce RILI while ensuring 
survival following irradiation.  To provide a uniform dose, 7 Gy was delivered with the 
animal in the supine position and 7 Gy was delivered with the animal in the prone position. 
Animals were returned to their cages and monitored daily for two weeks following the 
irradiation. A total of twenty rats were irradiated, of which six were used for 13C dynamic 
MRS and CSI of of the thorax, five were used for 13C dynamic MRS of the kidneys, five 
were used for assessment of paO2 and four were used to measure blood lactate concentration 
(as described further below). An equal number of age-matched healthy Sprague Dawley rats 
were used as controls for each measurement performed. Details for each sub-study are 
described below.  
2.2.2 Blood Lactate and paO2 Measurement 
In order to confirm the presence of RILI, paO2 levels were measured in an age-matched, 
irradiated cohort (n = 5) two weeks following irradiations and in a healthy cohort (n = 5). The 
two-week time point was chosen to yield maximum effect, based on the inflammatory and 
biochemical time course of RILI in a similar rat model shown in previous work by Calveley 
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et al. (8) Animals were initially anesthetized in an isoflurane induction chamber (Vet-Equip) 
at a flow rate of 0.8 L / min using a concentration of 5% isoflurane and were then transferred 
to a nose cone where the isoflurane concentration was reduced to 2% and a loading dose of 
ketamine hydrochloride was given at a dose of 50 mg/kg.  A 26 gauge catheter was inserted 
into the right tail vein to facilitate prolonged anesthesia depth by delivery of a mixture of 
propofol and ketamine at a ratio of 10:1 using an infusion pump with a dose rate of 50 
mg/kg/hr.  An incision was made across the neck in order to expose the right carotid artery, 
which was then isolated and cannulated with PE-50 tubing to allow arterial blood sampling 
and monitor blood pressure.  A 0.75 mL blood sample was then extracted and inserted into a 
CG4+ iStat cartridge for blood oxygenation analysis (iStat blood gas analyzer, Abbott 
Laboratories). 
In order to investigate potential systemic (ie. blood) RILI effects, that may influence the 
hyperpolarized 13C metabolic imaging studies, blood lactate concentration levels were 
measured directly from blood samples obtained in another age-matched cohort (n = 4) two 
weeks following irradiation as well as a healthy cohort (n = 4). Animals were initially 
anesthetized in an isoflurane induction chamber (Vet-Equip) at a flow rate of 0.8 L / min 
using a concentration of 5% isoflurane and were then transferred to a nose cone where the 
isoflurane concentration was reduced to 2%. A 26-gauge catheter was inserted into the tail 
artery to draw 0.5 ml of blood.  This blood sample was then extracted and inserted into a 
CG4+ iStat cartridge for blood lactate concentration analysis (iStat blood gas analyzer, 
Abbott Laboratories, Mississauga, ON). 
2.2.3 Hyperpolarized 13C pyruvate Preparation and Administration  
A mixture containing ~30 µl of [1-13C]-labelled pyruvic acid (CIL, Cambridge, MA) and 
15mM trityl radical (OX63, Oxford Instruments, UK) was hyperpolarized using a 
commercially-available DNP system (Hypersense, Oxford Instruments, UK) following a 
previously described protocol (24). In brief, the DNP system utilizes low temperatures (1.4 
K), high magnetic field strength (3.35 T) and microwave irradiation (94.15 GHz) to polarize 
the unpaired electrons in the radical that transfer the magnetization to 1-13C in the pyruvate 
molecule via the Nuclear Overhauser Effect (NOE) in the solid state. The hyperpolarized 
sample was rapidly dissolved in ~5.5 ml buffered (40 mM Tris) solution containing 80 mM 
Sodium Hydroxide, 0.1g/L Disodium EDTA dehydrate and 50mM Sodium Chloride to 
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effectively yield a 80 mM hyperpolarized pyruvate with a nominal pH of 7.4 upon 
dissolution. 
 
MRI and spectroscopy were performed approximately two weeks (14 days ± 2 days) 
following irradiation.  The experiments extended over four days to permit all twenty-two (11 
irradiated and 11 control) animals to be studied at approximately the same time post-
irradiation. The mean mass of the irradiated and healthy cohorts at the time of imaging was 
410 ± 50 g. Each rat was randomly chosen and measurements were made in a blinded 
fashion. On the day of measurements, the rats were anaesthetized using isoflurane. A catheter 
was inserted in the tail vein for injection of hyperpolarized 13C-pyruvate. The extension tube 
connecting the catheter to the hyperpolarized sample was 24-gauge and 90 cm in length. This 
tube made it possible to quickly inject the hyperpolarized sample while minimizing the dead 
space. Since the hyperpolarized pyruvate signal relaxes relatively quickly (T1 ~40 s) in 
vivo, MR spectroscopy data acquisition was started (as described below) immediately 
following bolus injection of 2.5 mL of 80 mM [1-13C] pyruvate in the tail vein of the rats (~ 
12 s). MRI data were acquired following a time delay (~ 25 s) to maximize lactate signal 
in the lung. This optimal time delay was based on the observed plateau in lactate signal 
measured with dynamic spectroscopy (see below).  
2.2.4 Magnetic Resonance Spectroscopy and Imaging 
MRI and spectroscopy were performed using a 3T MRI system (MR750, GEHC, Waukesha, 
WI) equipped with multinuclear hardware and software. The rat was supported in the bore of 
the magnet in the prone position using a custom tray equipped with a warming pad to 
maintain body temperature. A surface coil centered on the rat chest was fastened underneath 
the tray to acquire 1H images for localization purposes. The tray and surface coil were 
inserted into a custom-built, rat-sized quadrature transmit/receive bird-cage coil tuned to the 
13C Larmor frequency of 32.12 MHz. During MR measurements, the rats were kept 
anaesthetized with isoflurane (2 - 2.5%) provided by a nose cone delivery system.  Heart rate 
(320 - 360 beats per minute), breathing rate (40-60 breaths per minute) and core body 
temperature (37.0 - 37.8 °C) were monitored during the entire procedure (Small Animal 
Instruments Inc., Stony Brook, NY).  
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(A) 1H imaging: A gradient echo pulse sequence was used to acquire 1H images of the rat 
chest and kidney in the coronal and axial planes. The imaging parameters were as follows: 
FOV of 12 cm × 12 cm, matrix of 128 ×128, TE = 2 ms and TR = 34 ms, flip angle = 30 
degree. These images were used to position the 13C data acquisition slabs and FOV since the 
boundary of the lung was well visualized as a signal void compared to the other thoracic 
tissues (e.g. heart).  
 
(B) 13C Dynamic Spectroscopy: Based on the 1H coronal images, an axial slab (thickness = 
8.5 mm) was selected in medial regions of the lung, including the heart. Spectroscopic data 
were acquired from this slab in the irradiated cohort (n = 6) and healthy cohort (n = 6) using 
a ‘pulse-acquire’ pulse sequence with TR of 1 s following the injection of hyperpolarized 
13C-pyruvate. In total, 128 acquisitions were performed using flip angle = 10 degree, 
bandwidth = 5 kHz and 2048 points for a total scan time of 128 s. This dynamic spectroscopy 
data allowed measurements of total 13C signal in the slab as well as the time evolution of the 
pyruvate and lactate signals in order to time the spectroscopic imaging data acquisitions  
(described in section (C) below).  
 
To investigate possible indirect RILI effects outside the thorax, dynamic spectroscopy was 
performed over the kidney region in a separate age-matched irradiated cohort (n = 5) and 
healthy cohort (n = 5). An axial slab of thickness 10 mm was acquired in the region of the 
kidney, using 1H coronal images as a reference. 13C data were acquired with TR = 1 s, flip 
angle = 10 degree, bandwidth = 5 kHz and 2048 points for a total scan time of 128 s.  
 
(C) 13C Spectroscopic Imaging: Spectroscopic imaging was performed using a CSI 
technique from the same cohorts used in the 13C dynamic MRS studies of the thorax in 
irradiated rats (n = 4) and healthy rats (n = 4). A FOV of 6 cm × 6 cm was chosen 
corresponding to the same axial slab as described in section (B) above. A 16 × 16 matrix was 
prescribed with a nominal voxel size of 3.75 × 3.75 × 8.5 mm3. CSI data were acquired using 
a similar pulse-acquire approach as described above (flip angle of 10 degrees, bandwidth of 5 
kHz and 256 points) with a repetition time of 60 ms between each phase–encoding step for a 
total scan time of approximately 16 seconds. Based on the 13C dynamic spectroscopy 
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measurements (above), spectroscopic imaging was initiated following a delay of 25 seconds 
from the start of the bolus injection to maximize the lactate signal.  
 
(D) Data processing and analysis: SAGE™ software (GEHC, Waukesha, WI) was used for 
processing and visualization of the 13C data. For the dynamic spectroscopy protocol, the time 
domain data from each transient was apodized with a 2.5 Hz Gaussian filter then Fourier 
transformed. The spectra were then individually phased and baseline corrected. The lactate-
to-pyruvate signal ratio was computed by dividing the total pyruvate signal by the total 
lactate signal intensities obtained from the entire thorax or the kidney slab of the rat by 
integrating each metabolite peak at each time point and summing the peaks from 0 to 79 
seconds, after which the signal intensities were too small to measure.  
  
For the 13C spectroscopic imaging data, the time domain data were apodized with a 10 Hz 
Gaussian filter and Fourier transformed in both the time domain and the two spatial 
dimensions. The metabolite peaks were phased and baseline corrected for every voxel. The 
16x16 grid of spectra was overlaid on the axial 1H image and four voxels were chosen 
centered on the lung region and four voxels centered on the heart. The relative positions of 
these four voxels were kept consistent for both the heart and lung in each animal. The lactate-
to-pyruvate signal ratio for each voxel was computed by dividing the total pyruvate signal 
intensity by the total lactate signal intensity obtained in a given voxel by integrating each 
metabolite peak.  Two-tailed, paired T-tests were performed for the lactate-to-pyruvate ratios 
corresponding to the entire slab, as well as the lung and the heart for the irradiated cohort and 
the healthy cohort. A p-value of less than 0.05 was considered significant. Appendix A-2 
contains more details on the two-tailed paired T-test and the underlying assumptions.  
2.2.5 Microscopy of BAL Specimens 
Following MR measurements, BAL specimens were collected from the lungs of all the rats. 
10 mL of saline was injected into the lungs using an endotracheal tube. The saline was 
washed in and washed out three times to obtain a preliminary BAL specimen. This was 
repeated again to obtain a second specimen and combined with the first to obtain a final 
lavage specimen from the lungs. The BAL sample was then spun down at 1732 rpm for 10 
minutes, while keeping the temperature at 8 °C to separate the pellet of cells from the 
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supernatant fluid using a centrifuge (GS-15R, Beckman Coulter, Mississauga, ON). The 
pellet of cells was re-suspended in formalin and a smear placed on slides using a 
cytocentrifuge (Shandon Elliott Cytospin, Shandon Southern Instruments, Camberley, 
Surrey, England).  The cell smears were subsequently stained with hematoxylin and eosin 
(H&E) to identify cell nuclei (blue) from surrounding cytoplasm (pink).  The slides were 
visualized optically with a Zeiss AXIO Imager microscope (Carl Zeiss Canada ltd., Toronto, 
ON, Canada). The cell micrographs for healthy and irradiated animals were compared to 
provide a qualitative assessment of inflammation due to RILI. 
 
2.3. Results  
Figure 2-2 shows typical cell micrographs from a representative irradiated rat as well as a 
healthy rat.  At 40× magnification, more macrophages are evident in BAL specimens 
obtained from the irradiated cohort compared to BAL specimens obtained from the healthy 
cohort. At 100× magnification, monocytes, foamy macrophages and neutrophils are clearly 
seen in the BAL specimen from the irradiated cohort. Furthermore, some irregularities in the 
cell nucleus shape are also evident in the cells from the BAL of irradiated rats. These results 
qualitatively confirm the inflammatory response (i.e. RP) associated with RILI in the 
irradiated rats at the two-week time point.  
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Figure 2-2: Typical micrographs of H&E stained BAL specimens from (a) representative 
healthy rat and (b) representative irradiated rat (magnification of 40×).  The BAL specimens 
from the irradiated rats contained significant macrophages compared to the healthy group 
(shown by arrows). (c) BAL specimen from the representative irradiated rat seen at 
magnification of 100×. Foamy macrophages (FM), monocytes (M) and neutrophils (N) can 
be distinguished. 
The paO2 results are summarized in Figure 2-3. In this figure, the mean value of paO2 is 
shown with the error bars representing plus or minus one standard deviation based on the 
entire cohort. A statistically significant decrease in paO2 (p < 0.01) was observed in the 
irradiated cohort (54.2 ± 12.28 mmHg) compared to the healthy cohort (84.74 ± 9.98 
mmHg). The low paO2 measured in the irradiated cohort compared to the healthy cohort 
quantitatively confirms the presence of RILI, presumably causing tissue hypoxia.  
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Figure 2-3: Arterial partial pressure of oxygen from cohort of healthy and irradiated rats at 
two weeks. 
 
 
Figure 2-4: Lactate concentration measured from direct sampling of blood from irradiated 
and healthy rats. The lack of any significant difference confirms the absence of systemic 
spread of injury.  
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The blood lactate concentration levels are summarized in Figure 2-4. Mean lactate 
concentration is shown with error bars representing the standard deviation within the cohort. 
No statistically significant (p = 0.69) increase in blood lactate levels was observed in the 
healthy cohort (1.255 ± 0.247 mmol/L) compared to the irradiated cohort (1.325 ± 0.214 
mmol/L). Lack of a significant difference between blood lactate concentration levels between 
the two cohorts confirms the absence of any systemic (ie. blood) increase in lactate due to 
RILI. 
 
Figure 2-5: Representative normalized spectra showing sum of metabolites from time 0 to 
79 seconds over the entire slab from (a) healthy rat and (b) irradiated rat. Note the increase in 
the level of lactate in the irradiated rat. 
Figure 2-5 shows the summation of spectra from the hyperpolarized 13C dynamic MRS 
experiment from time 0 to 79 seconds corresponding to the entire slab in the lung region for a 
representative healthy rat as well as a irradiated rat. Figure 2-6 shows representative 13C-CSI 
data overlaid on the corresponding 1H image. The lactate-to-pyruvate signal ratio from the 
13C dynamic MRS data from the entire thorax was observed to increase in the irradiated 
cohort (0.128 ± 0.041) compared to the healthy cohort (0.061 ± 0.019), representing a 
statistically significant increase of approximately 110% in the entire thorax (p < 0.01).  
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Figure 2-6: Axial proton image with localized 13C spectra magnitude overlaid on top with 
highlighted voxels of interest in lung and heart.  Clear pyruvate and lactate peaks are 
observed in the heart and the lung region.  
The lactate-to-pyruvate signal ratios corresponding to the lung, heart and kidney tissues for 
both the healthy and irradiated cohorts are shown in Table 2-1. This table reports the mean 
values and the error bars represent plus or minus one standard deviation based on the entire 
cohort. The lactate-to-pyruvate signal ratios in the lung tissue were observed to increase in 
the irradiated rats (0.280 ± 0.054) compared to the healthy rats (0.178 ± 0.046), representing 
a statistically significant increase of approximately 57% (p < 0.02). Similarly, lactate-to-
pyruvate signal ratio in the heart tissue also showed a statistically significant increase of 
approximately 107% (p < 0.01) in the irradiated cohort (0.504 ± 0.083) compared to the 
healthy cohort (0.244 ± 0.035).  
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lactate/ 
pyruvate 
Healthy 
thorax 
(n= 6) 
Irradiate
d thorax 
(n=6) 
Healthy 
lung 
(n=4) 
Irradiate
d lung 
(n=4) 
Healthy 
heart 
(n=4) 
Irradiate
d heart 
(n=4) 
Healthy 
kidney 
(n=5) 
Irradiate
d kidney 
(n=5) 
Mean ±  
std. dev. 
0.061 ± 
0.019 
0.128 ± 
0.041 
0.178 ± 
0.046 
0.280 ± 
0.054 
0.244 ± 
0.035 
0.504 ± 
0.083 
0.215 ± 
0.100 
0.215 ± 
0.054 
Table 2-1: lactate-to-pyruvate signal ratio measured in the entire thorax (summed from 0 to 
79 seconds) as well as the lung, heart and kidney regions for healthy and irradiated rat 
cohorts. The data is represented as the mean ± standard deviation based on the respective 
cohorts. (Note: the lung and heart data for two of the rats had insufficient signal-to-noise 
ratio and are not included in the table and the kidney data shown above is from separate but 
identically irradiated and age matched healthy animal cohorts).  
These are depicted in Figure 2-7. In the cohort of irradiated and control rats 13C dynamic 
MRS data from which a slab through the kidneys was acquired, no statistically significant 
difference (p = 0.50) in lactate-to-pyruvate signal ratios between the healthy (0.215 ± 0.100) 
and irradiated cohorts (0.215 ± 0.054) was observed.  
 
Figure 2-7: Relative lactate-to-pyruvate signal ratio in the heart tissue and the lung tissue 
displayed. 
2.4. Discussion  
To our knowledge this is the first time that hyperpolarized 13C-pyruvate spectroscopic 
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imaging has been applied in vivo to assess lung metabolism. Specifically, lactate-to-pyruvate 
signal ratios are shown to be sensitive to metabolic changes associated with irradiation of the 
thorax in rats. The lactate-to-pyruvate signal ratio increased significantly in irradiated rats 
compared to age-matched, healthy rats. This increase in lactate-to-pyruvate signal ratio was 
demonstrated both for the entire thorax and regionally in the heart tissue and lung tissue. 
These increases are consistent with the expected changes in metabolism accompanying early 
RILI, namely anaerobic glycolysis due to underlying hypoxia. These results are also 
consistent with RP confirmed by micrographs of BAL smears reflecting a qualitative increase 
in the numbers of inflammatory cells in the lung. Furthermore, the absence of any change in 
lactate-to-pyruvate signal ratio in the kidney region nor any change in lactate levels in the 
blood of similarly irradiated rats compared to healthy age-matched rats confirms that the 
effects of injury are confined to the thorax region where radiation was directed and thus is a 
direct measure of RILI.  
A larger increase in lactate-to-pyruvate signal ratio was measured in the heart region of the 
irradiated animals compared to the healthy animals as compared to the lung region. This 
could have resulted from two possible factors. Firstly, the heart region is also irradiated in 
addition to the lung region, presumably leading to direct cardiac damage due to radiation.  
Secondly, due to the known compromise in lung function caused by the radiation as verified 
by paO2 measurements and cell micrographs, it is possible that the heart rate increased to 
compensate for low blood oxygenation to maintain the same amount of absolute oxygen 
delivery to the cells. Increase in workload on the heart and decrease in paO2 leading to lower 
paO2 in the coronary arteries could also potentially contribute to a higher lactate-to-pyruvate 
signal ratio observed in the heart region compared to the lung region. 
Hypoxia is expected in early RILI due to damage to blood vessels, especially in the lung, 
which is a particularly radiosensitive organ. While not measured directly and independently 
in this study, changes in lung perfusion due to RILI may also contribute to the increases in 
lactate-to-pyruvate signal increases observed.  The sensitivity of blood vessels to high 
radiation doses (i.e. hypofractionation) such as used in this study has been previously 
reported in the literature (6). Hypoxia was confirmed in this study by direct measurement of 
significant paO2 decreases in the irradiated rat cohort (54.2 ± 12.28 mmHg) compared to the 
healthy group (84.74 ± 9.98 mmHg). It has been well established clinically that a paO2 value 
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of less than 60 mmHg can lead to tissue hypoxia. (13) Decreases in paO2 following irradiation 
of lung tissue has been previously reported. (11, 12) These results suggest that enhanced 
lactate-to-pyruvate signal ratio may reflect early onset of RILI and could be correlated with 
the concurrent phase of RP. The advantage of this technique over clinical standards such as 
paO2 measurement is that it provides a localized measurement related to radiation injury and 
can potentially reveal regional variation in the severity of the injury. This is an important 
consideration from a clinical perspective as most treatment plans for lung cancer employ 
regional (i.e. conformal) radiation delivery. This study is a first step toward a longitudinal 
study of the effects of radiation dose, conformity and fractionation scheme that may help 
elucidate the mechanisms of RILI from a regional metabolism perspective. Other 
hyperpolarized 13C substrates such as 13C-bicarbonate may also be useful to measure regional 
changes in pH (32) associated with RILI and could provide information complementary to 
changes in pyruvate metabolism.  
Although data acquisition and post-processing were kept consistent within individual data 
sets in this study, variations could have been introduced by subjective tasks between data 
sets. In particular, phasing and baseline correction for spectra were performed manually. In 
this study, signals were localized to regions of the lung or heart only, therefore partial 
volume contamination from surrounding tissues was likely. The use of absolute fiducial 
markers for choice of 2D-CSI voxels within the heart and lung regions may help reduce 
variable partial volume effects in future. Sampling of BAL from the lungs and processing 
was also subjective in nature and could also have contributed to the uncertainty in cell 
micrographs. SNR could be improved by the use of even more sensitive surface coils, which 
would also aid in improving spatial resolution and/or performing 3D localization in the lung 
with the use of Echo Planar Spectroscopic Imaging (EPSI) (33, 34)  
In summary, hyperpolarized 13C-pyruvate spectroscopic imaging can detect increases in 
lactate-to-pyruvate signal ratio in the lung and heart tissue of rats as early as two weeks 
following whole-thorax irradiation. This is consistent with hypoxic tissue conditions and 
radiation pneumonitis, as confirmed by decreased paO2 and increases in inflammatory cells 
respectively in the irradiated animals compared to healthy rats. This study is an important 
first step in quantifying regional RILI by modifying fractionation schemes and/or conformal 
radiation therapy and/or applying adjuvant therapies for the mitigation of RP. Concurrent 
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development of human hyperpolarized 13C approaches could pave the way for the clinical use 
of this regional technique in future.  
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Chapter 3: Mapping metabolic changes associated with 
early Radiation-Induced Lung Injury post conformal 
radiation therapy using hyperpolarized 13C-pyruvate 
Magnetic Resonance Spectroscopic Imaging  
 
K. Thind, M. D. Jensen, E. Hegarty, A. P. Chen, H. Lim, P. Martinez, J. Van Dyk, E. Wong, 
T. J. Scholl2 and G. E. Santyr 
A shortened version of the manuscript below has been submitted to the journal of 
Radiotherapy and Oncology. August 2013. RO-D-13-00907 
3.1 Introduction  
Lungs cancer was the most prevalent type of cancer among men and the fourth most 
prevalent type of cancer among women globally in 2008. It was also responsible for the 
highest number of cancer related deaths in 2008. (1, 2) Radiation therapy is a primary 
treatment method for lung cancer (3) but leads to additional adverse consequences as the 
lungs are one of the more radiosensitive organs. (4) One of the major side effects of thoracic 
radiation therapy is RILI, which begins with inflammation of the lungs known as RP and can 
proceed to irreversible lung fibrosis in the later stages. (3) RILI occurs in up to 37% of lung 
cancer patients receiving radiation therapy (3, 5, 6), with moderate to severe RILI in about 
20% of patients. (7) Underlying anatomical and functional changes in RILI include 
thickening of septa, capillary damage and obstruction of airways leading to ventilation-
perfusion mismatch. These changes lead to symptoms such as shortness of breath, cough, 
fever and the need for oxygen therapy and ventilation support. (8, 9)  
Early detection of RP using imaging could potentially improve outcomes by appropriate 
modification of the radiation therapy treatment plan and/or administration of corticosteroids 
to help reduce inflammation. (10) Chest X-ray and CT imaging are currently the most 
commonly used methods for detection of RILI in the clinic. These techniques detect changes 
in lung density and can be useful for evaluation of fibrosis associated with late stage RILI 
stage, but generally provide no functional information. (11) SPECT using technetium-99m 
can provide regional ventilation and perfusion changes associated with the onset of RILI but 
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lacks specificity. (12) 3D-CT has been used to provide lung DVH parameters to predict the 
development of RP. (13) The two most common DVH parameters used as predictors of RILI 
are Vdose (percentage of CT-defined total lung volume receiving greater or equal than the 
threshold dose) and mean lung dose (average dose of the CT-defined total lung volume). 
However, these parameters have very low predictive powers. (3) 
Despite the low proton signal afforded in the lungs, MRI has been used for detection of RILI. 
Dynamic contrast-enhanced MRI with Gd-DTPA has been used to detect perfusion changes 
post-irradiation in dog lungs. (14) MRI has also been able to measure significant changes in 
relaxation times (T1 and T2) post-irradiation in rodent lungs. (15) More recently, 
hyperpolarized 3He-MRI has been used to detect regional changes in ADC and gas exchange 
associated with RILI in rodent lungs post irradiation. (16) Although these MRI developments 
show promise, they are still predominantly based on morphological and functional changes, 
which generally occur too late in RILI to mitigate. Imaging biomarkers sensitive to early 
metabolic changes associated with RP at the cellular level could provide an approach for 
earlier detection of RILI.  
At a cellular level, immunohistochemical analysis of RILI animal models reveals underlying 
changes in alveolar macrophages, inflammatory cytokines and type II pneumocytes. (17, 18) 
It is known that inflammatory cells are recruited from outside the radiation field following 
irradiation. (19) These infiltrating macrophages are a source of cytokines that are associated 
with the onset of inflammation in early RP. (20) RILI has also been shown to occur both in 
and out of the radiation field following conformal radiation therapy (21, 22), with the base of 
lung showing higher radiosensitivity than the apex. (21-24) Conformal radiation therapy of 
the base of the left and right lung leads to biphasic cytokine expression with the first wave 
occurring 24 hours post irradiation and the second wave occurring 5-15 days post irradiation, 
(25) along with DNA damage that occurs from a period of 3 days up to a period of 4 weeks 
post irradiation. Additionally, tissue hypoxia in the lungs plays a role in mediation of 
inflammatory process in RP. (26) Decreased paO2, which is used as an indicator of hypoxia 
(27) has been reported following radiation therapy. (28, 29) 
Advances in hyperpolarized MRI technology, specifically DNP, have enabled increases in 
the signal from 13C-substrates of a factor of up to 100,000, enabling in vivo detection with 
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high sensitivity. (30) Hyperpolarized endogenous liquid 13C-substrates can be safely injected 
into the bloodstream of animals and humans and the increased signal allows regional 
detection of the distribution of the injected 13C-labelled compounds and their metabolic 
products in real time. (31, 32) The pyruvate molecule enriched with 13C at the C-1 position 
has been used extensively since it can be polarized to a high degree and has a sufficiently 
long T1 for in vivo imaging (~40 s). High resolution spatial and temporal imaging of the 
conversion of 13C-pyruvate to its metabolic products, 13C-lactate, 13C-bicarbonate and 13C-
alanine, has been observed in vivo. (33-37) Specifically, changes in 13C-lactate to 13C-
pyruvate signal ratio (lac/pyr) have been used to measure lung ischemia ex vivo. (38) Our 
research has previously demonstrated changes in lac/pyr in a rat model of RILI at two weeks 
post whole thorax irradiation. (39) A longitudinal study of regional changes in metabolism 
following conformal radiation therapy would be a useful next step in the understanding the 
progression of RILI, specifically early detection of RP.  
The purpose of this work was to quantify regional lac/pyr using hyperpolarized 13C MRSI in 
a rat model of RILI involving conformal radiation therapy of the lungs, 5, 10, 15 and 25 days 
post-irradiation. These results were compared to those obtained in healthy age-matched rats 
and correlated with quantitative (i.e. cell counting) histological analysis of the lungs 
following imaging. The potential origin of lac/pyr changes in RP is discussed in terms of 
changes in cell populations, specifically macrophages.  
 
3.2 Methods 
3.2.1 Animal Irradiation 
All procedures followed animal care protocols approved by the Western University (ACVS) 
and were consistent with procedures used by the Canadian Council on Animal Care (CCAC). 
To induce RILI, 12 Sprague Dawley rats (200 ± 50 g) were irradiated with a total dose of 
18.5 Gy (two equal fractions of 9.25 Gy, 24 hours apart). The treatment plan consisted of two 
14×14mm2 opposed beams, incident on the dorsal and ventral surfaces.  
Irradiation was performed using a micro-RT system based on a modified micro-CT (GE 
eXplore CT 120, GE Healthcare, Milwaukee WI USA), similar to a system previously 
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described. (40-42) For the micro-RT application, the micro-CT system was upgraded with 
the addition of a more powerful x-ray generator and computer-controlled variable aperture 
collimator. Image-guidance was performed using both planar fluoroscopy and micro CT 
scanning. The therapeutic beam had energy of 140kVp with a Half Value Layer (HVL) of 6 
mmAl. It was filtered by 4.5 mmAl to harden the beam for deeper penetration. The beam was 
pulsed at approximately 10% duty cycle, with pulse duration of 125 ms at 63 mA. The 
resulting dose rate was approximately 0.15 Gy/min including additional cooling breaks. 
Delivery of each fraction required approximately 1.5 hours, with 1 hour needed for 
irradiation and the remainder for imaging and setup. The animals were imaged with 
fluoroscopy prior to therapy to localize the right lung. The collimator jaws were set to place a 
14x14mm2 field on the lower-medial right lung at end expiration such that the diaphragm and 
heart were shielded. Figure 3-1 shows the simulated conformal dose distribution in the lungs 
and heart region of rat thorax for a single fraction (9.25 Gy).  
 
Figure 3-1: Calculated dose distributions shown in (a) axial plane, (b) coronal plane and (c) 
sagittal planes. The yellow contour around the right lung represents the isodose line 
corresponding to 9 Gy. Most of the heart region and left lung received minimal radiation 
dose (< 0.5 Gy). The dose delivery was gated to the breathing cycle for accurate dose 
deposition.  
 During the irradiation procedures, the rats were anesthetized using isoflurane initially in an 
induction chamber at 5%, and then transferred to a nose cone at 1.5 – 2.5% at a gas flow rate 
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of 1.0 L/min medical oxygen. Lacrilube® (Allergan Inc, Markham, Canada) was applied 
gently to both eyes to reduce the effect of dehydration. Animals were placed supine on the 
micro-RT couch and were kept warm during the irradiation using a heating pad. A small 
animal monitoring system (Small Animal Instruments Inc., Stony Brook, NY) was used to 
monitor core body temperature and detect the breathing cycle to trigger the beam for gated 
delivery of the radiation. Breathing rate was kept consistent at 50-60 breaths per minute by 
regulating the amount of isoflurane and dose was delivered only during the expiration phase 
of the breathing cycle for better dose registration. Animals were returned to high efficiency 
particulate air (HEPA) filtered cages after the procedure. An equal number of age-matched 
healthy Sprague Dawley rats were also housed in HEPA filtered cages and were used as 
controls for MRI, blood analysis and histological measurements.  
3.2.2 Blood Lactate and paO2 Measurements 
In order to investigate systemic effects of conformal radiation therapy, blood lactate 
concentration levels were measured in the irradiated cohort (n = 3) and corresponding age-
matched healthy cohort (n = 3) at day 5, 10, 15 and 25-post irradiation. paO2 levels were also 
measured in each animal to quantify hypoxia post irradiation, using 60 mmHg as a clinical 
threshold to classify hypoxic tissue environment. (27) To obtain the arterial blood, animals 
were initially anesthetized in an isoflurane induction chamber (Vet-Equip) at a flow rate of 
0.8 L / min using a concentration of 5% isoflurane and were then transferred to a nose cone 
where the isoflurane concentration was reduced to 2%.  A 26-gauge catheter was inserted 
into the tail artery and a 0.75 mL blood sample was then extracted and inserted into a CG4+ 
iStat cartridge for blood lactate concentration and paO2 measurement (iStat blood gas 
analyzer, Abbott Laboratories, Mississauga, ON). Two-tailed paired T-tests were performed 
on blood lactate concentration and paO2 level between the healthy and irradiated cohorts for 
each time point. Appendix A-2 contains more details on the two-tailed paired T-test and the 
underlying assumptions. 
3.2.3 Hyperpolarized 13C-pyruvate Preparation, Administration and MRI 
Approximately 30 µl of [1-13C]-labelled pyruvic acid (CIL, Cambridge, MA) was mixed with 
15mM trityl radical (OX63, Oxford Instruments, UK) and was hyperpolarized using a 
commercial DNP system (Hypersense, Oxford Instruments, UK). The hyperpolarization 
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protocol has been described in detail previously. (43) During dissolution, the hyperpolarized 
sample was readily dissolved in ~5.5 ml buffered (40 mM Tris) solution containing 80mM 
Sodium Hydroxide, 0.1g/L Disodium EDTA dehydrate and 50mM Sodium Chloride to yield 
a 80 mM hyperpolarized pyruvate with a nominal pH of 7.4.  
MRI was performed on the irradiated cohort (n = 3) and corresponding age-matched healthy 
cohort (n = 3) at day 5, 10 ± 1, 15 ±1 and 25 ± 1 post irradiation for a total of 12 irradiated 
rats and 12 healthy rats. For each cohort, rats were randomly chosen and measurements were 
performed in a blinded fashion. The rats were anesthetized using initial bolus of 5% 
isoflurane at a flow rate of 0.8 L / min and were then transferred to a nose cone where the 
isoflurane concentration was reduced to 2%. After blood lactate concentration and paO2 
measurements, a catheter was inserted in the tail vein for injection of hyperpolarized 13C-
pyruvate. The extension tube connecting the catheter to the hyperpolarized sample was 24-
gauge and 90 cm in length.  
3.2.4 Magnetic Resonance Spectroscopy and Imaging 
MRI and MRSI were performed using a 3T MRI system (MR750, GEHC, Waukesha, WI) 
equipped with multinuclear hardware and software as described previously. (39) The animal 
was supported in the prone position with a custom-built tray equipped with a warming pad to 
maintain body temperature. They tray included a nose cone that supplied 2 – 3% isoflurane at 
0.8 L/min flow rate to maintain anaesthesia during the experiment. A custom surface coil 
resonant at the 13C Larmor frequency (32.12 MHz) was wrapped around the animal thorax. 
The tray was then inserted into a custom-built, rat-sized quadrature dual-tuned birdcage coil 
resonant at both the 1H Larmor frequency and 13C Larmor frequency. The birdcage coil was 
used to transmit/receive signal for 1H MRI and to transmit 13C signal only. The 13C surface 
coil was used to receive signal for 13C MRSI. This TORO setup for reception of 13C-signal 
enhanced the 13C-SNR by up to 4 times and is discussed in more detail in Appendix A-1. 
Heart rate (320-360 beats per minute), breathing rate (40-60 breaths per minute) and core 
body temperature (37.0-37.8 °C) were monitored during the entire MRI experiment (Small 
Animal Instruments Inc., Stony Brook, NY).  
 
1H MRI: A gradient echo pulse sequence was used to acquire T1 -weighted 1H images of the 
rat thorax in the coronal and axial planes. The imaging parameters were as follows: FOV = 
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12 cm × 12 cm, matrix = 128×128, TE = 2 ms and TR = 34 ms, flip angle = 30 degree, slice 
thickness = 3 mm. These images were used to localize the 13C data acquisition volume of 
interest in the lungs as the boundary of the lungs was well visualized as a signal void 
compared to the other tissues (e.g. heart and liver).  
 
13C MRSI: MRSI was performed using a CSI technique described previously.(39) An axial 
FOV of 6 cm × 6 cm was chosen centred on the lungs, avoiding liver and large regions of the 
heart. A 12 × 12 matrix was prescribed in the FOV with a slice thickness of 8 mm. CSI data 
were acquired using a pulse-acquire approach (flip angle of 10 degrees, bandwidth of 5 kHz 
and 256 points) with a repetition time of 80 ms for a total scan time of approximately 12 
seconds. Spectroscopic imaging was initiated following a delay of 25 seconds from the start 
of the bolus injection to maximize the lactate signal. The optimum lactate window was based 
on previous 13C dynamic spectroscopy experience with a similar RILI rat model. (39) 
 
MR data processing and analysis: SAGE™ software (GEHC, Waukesha, WI) was used for 
processing and visualization of the 13C data overlaid on 1H localization images. The 13C 
spectroscopic imaging data were apodized with a 10 Hz Gaussian filter in the time domain, 
zero-filled 1× in the time dimension and both spatial dimensions. Fourier transformations 
were then performed in both the time domain and the two spatial dimensions to obtain a 16 × 
16 grid of spectra with each voxel dimension of 3.75 mm × 3.75 mm × 8 mm. The metabolite 
peaks were phased and baseline corrected for every voxel. The 16 × 16 grid of spectra was 
overlaid on the axial 1H image and twelve voxels were chosen: four centred on the left lung, 
four on the right lung and four on the heart. The relative positions of these four voxels for 
each organ were kept consistent for each animal. The measure of lac/pyr for each group of 
four voxels was computed by dividing the total lactate signal intensity in the four voxels by 
the total pyruvate signal intensity in the four voxels, obtained by summing the appropriate 
integrated metabolite peak in each voxel. Two-tailed, paired T-tests were performed for the 
lac/pyr measurements corresponding to the left lung, the right lung and the heart between the 
irradiated cohort and the healthy cohort for each time point. A p-value of less than 0.05 was 
considered significant. A mixed analysis of variance with repeated measures at each time 
point was also run on the data to determine any within- or between-subject interactions using 
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SPSS software. (IBM, Markham, Ontario). Appendix A-2 contains more details on the two-
tailed paired T-test and mixed analysis of variance including the underlying assumptions. 
3.2.5 Histology Preparation and Analysis 
 Following MRI, the rats were euthanized using an injection of 540 mg/kg rat mass of 
sodium pentobarbital (Euthanyl Forte, Bimeda-MTC, Cambridge, Canada) and the lungs 
extracted for histological analysis. The lungs were fixed by intratracheal infusion of 8 mL of 
10% neutral-buffered formalin.  The fixed lungs specimens were embedded in paraffin, cut 
into 5 µm thick tissue sections and stained with H&E. Using a Zeiss Axio Imager microscope 
(Toronto, Ontario, Canada), five representative images, at a magnification of 40 times and a 
FOV of 240 µm by 320 µm, of the caudal lobe of right lung and from the basal left lobe were 
taken using a Retiga EXi Digital CCD camera (Q imaging, Vancouver, BC, Canada) attached 
to the microscope. Areas selected contained predominantly alveolar duct and alveoli, 
avoiding any major airways and blood vessels. The infiltrating macrophages were counted 
manually in each image to obtain macrophage density and were used as a gauge for injury 
during RP. The criteria for counting macrophages were consistent for all images and were 
defined as larger cells with clear boundaries and darker cytoplasm. Figure 3-2 shows a 
representative H&E stained section of the right lung at day 25 for both a healthy and an 
irradiated rat with the macrophages marked by black arrows. 
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Figure 3-2: Section of H&E slide from lower right lung of a healthy (unirradiated) rat at day 
25 (a) and from lower right lung of an irradiated rat at day 25 post-irradiation (b). There is a 
clear increase in the number and size of macrophages as marked by the black arrows in the 
irradiated lungs compared to the unirradiated lungs.  
3.3 Results 
Figure 3-3 shows a typical CSI grid overlaid on the corresponding 1H image for a 
representative RILI rat, including the voxels chosen for analysis of lac/pyr in left lung, right 
lung and heart region respectively. Figure 3-4 provides a summary of the average lac/pyr 
measurements obtained from these regions in both the irradiated and healthy cohorts at day 5, 
10, 15 and 25-post irradiation. Both the right lung and the left lung from the irradiated cohort 
show a statistically significant increase in lac/pyr compared to the right lung and left lung 
from the healthy cohort respectively at each time point. This confirms the response to 
radiation both at the site of the irradiation (radiation therapy to medial right lung) as well as 
the unirradiated  (i.e. contralateral) left lung. The enhanced lac/pyr in the contralateral lung 
was evident at all four time points and did not vary substantially from one time point to 
another. Elevated lac/pyr in the right lung of irradiated cohort was consistent across all time 
points.  
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Figure 3-3: 13C MRSI overlaid on T1-weighted 1H axial image. The lung boundary is clearly 
visualized by as signal void. 13C measurements were made in twelve voxels, four each from 
the left lung, right lung and the heart region are indicated as a), b) and c) respectively. Voxel 
positions with respect to the 1H image were kept consistent for all animals.  
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Figure 3-4: Measurement of lac/pyr plotted for the right lung, left lung and heart regions in 
the healthy and irradiated cohorts at all four time points post irradiation. Statistically 
significant increases in lac/pyr (** p < 0.01, * p < 0.05) are apparent in the right lung and left 
lung of the irradiated cohort compared to right lung and left lung of the healthy cohort or the 
heart region at all time points post irradiation.  
Additionally, mixed analysis of variance demonstrated a statistically significant decrease in 
lac/pyr at day 25-post irradiation in the right lung of irradiated cohort compared to lac/pyr at 
day 10-post irradiation in the right lung of the irradiated cohort (p < 0.05), suggesting the 
initial phase of radiation induced effects beginning to subside. Table 3-1 summarizes lac/pyr 
(mean ± first standard deviation) from the right lung, left lung and heart for irradiated and 
healthy cohort for all time points.  
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Table 3-1: Summary of lac/pyr from the right lung, left lung and heart regions and 
macrophage count from right lung and left lung of the irradiated and healthy cohorts at each 
time point post conformal radiation therapy. Data is represented as mean ± standard 
deviation.  
Measured lac/pyr was not statistically significant higher in the heart region of the irradiated 
cohort compared to the heart region of healthy cohort at day 5, 10 and 15-post irradiation. At 
day 25, lac/pyr was lower in the heart region of the irradiated cohort than the heart region of 
the healthy cohort (0.21 ± 0.01 vs. 0.25 ± 0.01, n = 3, p < 0.05). Analysis of the histology 
 lac/pyr Macrophage count 
 Day 5 Day 10 Day 15 Day 25 Day 5 Day 10 Day 15 Day 25 
Irradiated 
cohort right 
lung (n = 3) 
0.37 ± 
0.04 
0.39 ± 
0.02 
0.37 ± 
0.02 
0.33 ± 
0.02 
18.13 
± 1.53 
14.80 ± 
1.70 
14 ± 
1.41 
13.80 ± 
2.26 
Healthy 
cohort right 
lung (n = 3) 
0.17 ± 
0.06  
0.26 ± 
0.06 
0.24 ± 
0.03 
0.21 ± 
0.03 
7.40 ± 
1.56 
9.33 ± 
3.39 
7.53 ± 
1.15 
6.80 ± 
0.35 
Irradiated 
cohort left 
lung (n = 3) 
0.39 ± 
0.04 
0.38 ± 
0.07 
0.41 ± 
0.08 
0.35 ± 
0.03 
15.47 
± 1.81 
14.60 ± 
1.13 
14.13 ± 
1.50 
13.33 ± 
1.70 
Healthy 
cohort left 
lung (n = 3) 
0.17 ± 
0.05 
0.22 ± 
0.04 
0.21 ± 
0.07 
0.20 ± 
0.01 
7.13 ± 
1.50 
9.30 ± 
3.25 
8.07 ± 
1.45 
6.47 ± 
0.76 
Irradiated 
cohort heart 
(n = 3) 
0.22 ± 
0.04 
0.21 ± 
0.03 
0.25 ± 
0.04 
0.21 ± 
0.01 
    
Healthy 
cohort heart 
(n = 3) 
0.18 ± 
0.01 
0.24 ± 
0.05 
0.28 ± 
0.08 
0.25 ± 
0.01  
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from the heart region at day 10 and day 15-post irradiation confirmed that they did not show 
any signs of injury.  
Analysis of blood lactate concentration levels did not show statistically significant changes 
between the irradiated and healthy cohorts at any time point post irradiation. Measurement of 
blood lactate from all irradiated and healthy cohorts (non time point specific) was 1.22 ± 0.3 
mM (n = 12) and 1.23 ± 0.31 mM (n = 12) respectively. Additionally, blood paO2 level 
measurement for all irradiated and healthy cohorts (non time point specific) was 80 ± 15 
mmHg (n = 12) and 78 ± 14 mmHg (n = 12) respectively. paO2 did not drop below normal 
(60 mmHg) for any irradiated cohorts and there was a lack of a statistically significant 
change in paO2 level between irradiated cohorts and healthy cohorts at any time point post 
irradiation.  
Table 3-1 summarizes the macrophage count for right lung and left lung from irradiated and 
healthy cohorts at each time point. Figure 3-5 shows the time courses for average lac/pyr and 
macrophage count for all time points for both the right and left lung of both cohorts. 
Macrophage counts were observed to increase in both the left and right lung of the irradiated 
cohort compared to the healthy cohort, following a trend similar to lac/pyr at each time point. 
Figure 3-6 shows a scatter plot of the lac/pyr measurements versus macrophage count for the 
right and left lung of all the rats for all time points. Non-parametric analysis of these data 
provided Spearman coefficients (r) of 0.86 (p < 0.01) and 0.85 (p < 0.01) respectively for the 
right and left lung. The strong correlation between lac/pyr and macrophage count suggests 
that the enhanced lac/pyr seen in the irradiated cohort is likely due to inflammation 
associated with RP, potentially up-regulation of macrophage activity.  
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Figure 3-5: Time evolution of the average lac/pyr in healthy and irradiated cohorts in the 
right lung (a) and left lung (b) for the healthy and irradiated cohorts. The corresponding 
macrophage counts are shown in (c) and (d). A similar time trend can be seen for both lac/pyr 
and macrophage count. 
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Figure 3-6: Scatter plot of lac/pyr versus macrophage count in right lung (a) and left lung (b) 
for all rats showing strong correlation in both the right lung (r = 0.86, p < 0.01) and the left 
lung (r=0.85, p < 0.01) respectively. 
 
3.4 Discussion 
To our knowledge this is the first time that hyperpolarized 13C-pyruvate MRSI has been used 
to assess the early phases of RILI longitudinally following conformal radiation therapy, 
specifically RP. In this rat model of RILI involving conformal irradiation of the right lung, 
measures of lac/pyr were shown to be elevated in both right and left lung at all time points (5, 
10, 15 and 25 days) following irradiation. This is consistent with previous observations in a 
similar rat model, which showed that cytokines and DNA damage persist 5 to 15 days and 3 
days to 4 weeks post irradiation respectively. (25) The statistically significant decrease in 
lac/pyr in the right irradiated lung observed at day 25 compared to day 10 may be evidence 
of reduced inflammation from the receding initial phase of RP.  This seems to be supported 
by the reduction in measured macrophage activity at the later time points (Figure 3-5).  
Additionally, lac/pyr was also shown to detect the response of the entire lungs to conformal 
radiation therapy (medial right lung) both at the site of irradiation but also on the unirradiated 
contralateral side (left lung). This observation is in agreement with previous findings, which 
have demonstrated that conformal radiation therapy of the lungs results in injury response of 
the lungs both in and out of the radiation field (21, 22).  
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Measurements of lac/pyr did not show altered heart metabolism at any time point. This was 
confirmed by the analysis of the histology from the heart region. Analysis of the lactate 
concentration and paO2 levels of the blood also showed no statistically significant difference 
between the healthy and irradiated cohorts for any time points. Lack of change in both 
lac/pyr in the heart region and in blood lactate levels between the two cohorts demonstrates 
that the injury response was only in the lungs with no systemic effects. This confirms that the 
irradiation conformed to the right lung, sparing other surrounding tissues. As expected, this 
was not seen in our previous studies involving whole-thorax irradiation, which resulted in a 
significant increase in lac/pyr in the heart tissue and increases in blood lactate levels at 2 
weeks post-irradiation. (39)  
The lack of a paO2 decrease (below 60 mmHg) in any of the rats at any time point and the 
lack of a statistically significant change in paO2 level between healthy and irradiated cohorts 
confirms the response to radiation was confined to the lungs.  Unlike our previous finding of 
decreased paO2 in the blood following whole thorax irradiation (41), the conformal 
irradiation of the right lung does not appear to compromise the lung function and could be 
attributed to the compensatory effects of the unirradiated lung, enabling adequate oxygen 
supply to the body. In addition to the conformal radiation therapy, the lower dose rate of the 
radiation beam used in this study may also have reduced the level of tissue injury.  
Figure 3-5 shows that the macrophage count in both the left and right lung of the irradiated 
cohort was higher than the corresponding left and right lung of the healthy cohort. Previous 
studies have shown that macrophages are recruited from outside the radiation field post 
irradiation (19) and that these infiltrating macrophages are a source of cytokines associated 
with onset of inflammation in early RP. (20) As such, macrophage count is a useful 
quantitative indicator of the inflammation in early RILI. Additionally, the error bars (single 
standard deviation) on macrophage count as shown in Figure 3-5 c) and d) do not overlap 
between the healthy and irradiated cohort at any time point in either the left lung or the right 
lung. This trend is similar to lac/pyr trends observed in the healthy and irradiated cohorts 
(Figure 3-5 a) and b)). The hypothesis that lac/pyr changes may be a reflection of increased 
macrophage activity associated with RP is further supported by the strong correlation 
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between macrophage count and lac/pyr for the right lung (r = 0.86, p < 0.01) and the left lung 
(r = 0.85, p < 0.01). This hypothesis also seems to be supported by previous evidence linking 
increases in lac/pyr with inflammation in other disease (arthritis) models. (44) Increasing the 
sample size (n > 3) should result in more powerful statistics and better quantification of 
lac/pyr and macrophage count to further support this hypothesis.  Staining for particular 
macrophage type and following the evolution of type II pneumocyte population post 
irradiation could provide further insight into the progression of RILI.  
In summary, early metabolic changes (over days) can be mapped using hyperpolarized 13C-
pyruvate MRSI in a rat model of RILI using conformal radiation therapy. Specifically, 
lac/pyr is observed to increase in irradiated and unirradiated lung regions consistent with 
histological changes associated with radiation pneumonitis. Increases in lac/pyr are highly 
correlated with macrophage count in both the irradiated and unirradiated lung suggesting that 
part of the enhanced lac/pyr may be caused by an increase in the number and activity of 
resident and infiltrating inflammatory macrophages. Future studies could focus on the use of 
hyperpolarized 13C-pyruvate MRSI to measure the effects on radiation pneumonitis arising 
from varying conformal radiation therapy (dose, dose rate, fractionation scheme etc.) and 
intervention during the course of the injury for mitigation of RILI. Furthermore, application 
of this technique in a clinical environment should also be possible with the recent availability 
of hyperpolarized 13C-pyruvate for human use.  
 
3.5 Acknowledgements 
The authors wish to thank the Foster lab for their assistance with microscopy, Ian Welsh for 
his assistance with histology and Yves Bureau for his assistance with statistics. This work 
was supported by an operating grant from the Canadian Institutes for Health Research. KT 
was supported by an Ontario Graduate Scholarship and Canadian Institutes for Health 
Research Strategic Training Program in Cancer Research and Technology Transfer.   
 
  
 82 
 
3.6 References 
 
1. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA: a cancer journal for 
clinicians 2011;61:25. 
2. Are C, Rajaram S, Are M, et al. A review of global cancer burden: Trends, 
challenges, strategies, and a role for surgeons. Journal of Surgical Oncology 2012. 
3. Rodrigues G, Lock M, D'Souza D, et al. Prediction of radiation pneumonitis by dose - 
volume histogram parameters in lung cancer--a systematic review. Radiotherapy and 
Oncology 2004;71:127-138. 
4. M. Bentzen JS, J. Bernier, S. Quantitative clinical radiobiology of early and late lung 
reactions. International journal of radiation biology 2000;76:453-462. 
5. Movsas B, Raffin TA, Epstein AH, et al. Pulmonary radiation injury. Chest 
1997;111:1061-1076. 
6. Schroeder MA, Atherton HJ, Cochlin LE, et al. The effect of hyperpolarized tracer 
concentration on myocardial uptake and metabolism. Magnetic Resonance in 
Medicine 2009;61:1007-1014. 
7. Mehta V. Radiation pneumonitis and pulmonary fibrosis in non small-cell lung 
cancer: Pulmonary function, prediction, and prevention. International Journal of 
Radiation Oncology  Biology Physics 2005;63:5-24. 
8. Rubin P, Casarett GW. Clinical radiation pathology as applied to curative 
radiotherapy. Cancer 1968;22:767-778. 
9. Gross NJ. Pulmonary effects of radiation therapy. Annals of internal medicine 
1977;86:81-92. 
10. Wiebe E, Rodrigues G. Radiation-Induced Lung Injury Strategies for reducing 
damage while optimizing therapeutic dosage. Protocols & Practicies 2006;5. 
11. Ghafoori P, Marks LB, Vujaskovic Z, et al. Radiation-induced lung injury. 
Assessment, management, and prevention. Oncology 2008;22:37-47; discussion 52-
33. 
12. Evans ES, Hahn CA, Kocak Z, et al. The role of functional imaging in the diagnosis 
and management of late normal tissue injury. Seminars in radiation oncology 
2007;17:72-80. 
13. Graham MV. Predicting radiation response. International Journal of Radiation 
Oncology Biology Physics 1997;39:561. 
 83 
 
14. Nobuhiko Ogasawara KS, Yuichi Karino, Naofumi Matsunaga. Perfusion 
characteristics of radiation- injured lung on GD-DTPA-enhanced dynamic magnetic 
resonance imaging. Investigative Radiology 2002;37:10. 
15. Shioya S TC, Kurita D, Katoh H, Tsuda M, Haida M, Kawana A, Ohta Y. Early 
damage to lung tissue after irradiation detected by the magnetic resonance T2 
relaxation time. Radiation research 1997;148:359-364. 
16. Ward ER, Hedlund LW, Kurylo WC, et al. Proton and hyperpolarized helium 
magnetic resonance imaging of radiation-induced lung injury in rats. International 
journal of radiation oncology, biology, physics 2004;58:1562-1569. 
17. Johnston CJ, Piedboeuf B, Baggs R, et al. Differences in correlation of mRNA gene 
expression in mice sensitive and resistant to radiation-induced pulmonary fibrosis. 
Radiation research 1995;142:197-203. 
18. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. 
Radiotherapy and Oncology 1995;35:83-90. 
19. Johnston CJ, Williams JP, Elder A, et al. Inflammatory cell recruitment following 
thoracic irradiation. Experimental lung research 2004;30:369-382. 
20. Hong J-H, Jung S-M, Tsao TCY, et al. Bronchoalveolar lavage and interstitial cells 
have different roles in radiation-induced lung injury. International journal of 
radiation biology 2003;79:159-167. 
21. Khan MA, Hill RP, Van Dyk J. Partial volume rat lung irradiation: An evaluation of 
early DNA damage. International Journal of Radiation Oncology Biology Physics 
1998;40:467. 
22. Khan MA, Van Dyk J, Yeung IW, et al. Partial volume rat lung irradiation; 
assessment of early DNA damage in different lung regions and effect of radical 
scavengers. Radiotherapy and Oncology 2003;66:95-102. 
23. Liao Z-X, Travis EL, Tucker SL. Damage and morbidity from pneumonitis after 
irradiation of partial volumes of mouse lung. International Journal of Radiation 
Oncology Biology Physics 1995;32:1359-1370. 
24. Travis EL, Liao Z-X, Tucker SL. Spatial heterogeneity of the volume effect for 
radiation pneumonitis in mouse lung. International Journal of Radiation Oncology 
Biology Physics 1997;38:1045-1054. 
25. Calveley VL, Khan MA, Yeung IW, et al. Partial volume rat lung irradiation: 
temporal fluctuations of in-field and out-of-field DNA damage and inflammatory 
cytokines following irradiation. International journal of radiation biology 
2005;81:887-899. 
 84 
 
26. Vujaskovic Z, Anscher MS, Feng Q, et al. Radiation-Induced Hypoxia may 
prepetuate late normal tissue injury. International journal of radiation oncology, 
biology, physics 2001;50:5. 
27. Equine Respiratory medicine and surgery: A Saunders Ltd.; 2006. 
28. Dietmar Siemann RH. Quantitative changes in the arterial blood gases of mice 
following localized irradiation of the lungs. Radiation research 1983;93:560-566. 
29. Emirgil C, Heinamann HO. Effects of irradiation of chest on pulmonary function in a 
man. Journal of applied physiology 1961;16:331-338. 
30. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of 
> 10,000 times in liquid-state NMR. Proceedings of the National Academy of 
Sciences of the United States of America 2003;100:10158-10163. 
31. Golman K. Molecular imaging using hyperpolarized 13C. British Journal of 
Radiology 2003;76:S118-S127. 
32. Golman K, Zandt RI, Lerche M, et al. Metabolic imaging by hyperpolarized 13C 
magnetic resonance imaging for in vivo tumor diagnosis. Cancer research 
2006;66:10855-10860. 
33. Albers MJ, Bok R, Chen AP, et al. Hyperpolarized 13C lactate, pyruvate, and 
alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer 
research 2008;68:8607-8615. 
34. Atherton HJ, Schroeder MA, Dodd MS, et al. Validation of the in vivo assessment of 
pyruvate dehydrogenase activity using hyperpolarised (13) C MRS. NMR in 
biomedicine 2011;24:201-208. 
35. Day SE, Kettunen MI, Cherukuri MK, et al. Detecting response of rat C6 glioma 
tumors to radiotherapy using hyperpolarized [1- 13C]pyruvate and 13C magnetic 
resonance spectroscopic imaging. Magnetic resonance in medicine 2011;65:557-563. 
36. Day SE, Kettunen MI, Gallagher FA, et al. Detecting tumor response to treatment 
using hyperpolarized 13C magnetic resonance imaging and spectroscopy. Nature 
medicine 2007;13:1382-1387. 
37. Hu S, Chen AP, Zierhut ML, et al. In vivo carbon-13 dynamic MRS and MRSI of 
normal and fasted rat liver with hyperpolarized 13C-pyruvate. Molecular imaging 
and biology 2009;11:399-407. 
38. Pullinger B, Profka H, Ardenkjaer‚ Larsen J, et al. Metabolism of hyperpolarized [1-
13C] pyruvate in the isolated perfused rat lung-an ischemia study. NMR in 
biomedicine 2012. 
 85 
 
39. Thind K, Chen A, Friesen‚ÄêWaldner L, et al. Detection of radiation-induced lung 
injury using hyperpolarized 13C magnetic resonance spectroscopy and imaging. 
Magnetic Resonance in Medicine 2012. 
40. Graves EE, Zhou H, Chatterjee R, et al. Design and evaluation of a variable aperture 
collimator for conformal radiotherapy of small animals using a microCT scanner. 
Medical physics 2007;34:4359. 
41. Rodriguez M, Zhou H, Keall P, et al. Commissioning of a novel microCT/RT system 
for small animal conformal radiotherapy. Physics in medicine and biology 
2009;54:3727. 
42. Zhou H, Rodriguez M, Van den Haak F, et al. Development of a Micro-Computed 
Tomography-Based Image-Guided Conformal Radiotherapy System for Small 
Animals. International Journal of Radiation Oncology Biology Physics 2010;78:297-
305. 
43. Kohler SJ, Yen Y, Wolber J, et al. In vivo 13 carbon metabolic imaging at 3T with 
hyperpolarized 13C-1-pyruvate. Magnetic resonance in medicine 2007;58:65-69. 
44. Weibel ER. What makes a good lung. Swiss medical weekly 2009;139:375-386. 
 
 
 
 86 
 
Chapter 4: Rapid and Accurate Mapping of pH using 
Spiral-IDEAL with Hyperpolarized 13C-bicarbonate  
 
K. Thind, C. N. Wiens, A. P. Chen, H. Lim, P. Martinez, A. Ouriadov, C.A. McKenzie, T. J. 
Scholl, R. F. Schulte, G. E. Santyr 
An updated version of the following chapter will be submitted to Magnetic Resonance in 
Medicine as a Technical Note. 
4.1 Introduction 
Many fundamental physiological mechanisms in the human body depend on pH balance, 
thereby making pH regulation one of the most important homeostatic processes (1). Two 
major endogenous buffers that regulate pH are the phosphate buffer and the bicarbonate 
buffer. Specifically, the bicarbonate buffer is responsible for 86% of the extracellular 
buffering capacity. (2) Physiologically stable pH is measured at 7.35 – 7.45 for the human 
body. (3) Disruption of pH balance, local or systemic can result from a variety of disorders 
such as cancer, metabolic acidosis, chronic respiratory acidosis, stroke, cardiac failure, 
inflammation and infection. These disorders cause major changes in physiology such as 
altered energy metabolism, perfusion changes, failure of Na+/H+ transporters and lower lung 
tidal volumes (4). As a result of these changes, enhanced anaerobic glucose metabolism leads 
to accumulation of lactic acid and in combination with poor perfusion and reduced 
bicarbonate buffering capacity, lead to an acidic extracellular pH (pHe) (5). Although 
measurement of blood pH using an electrophysiological probe can indicate a systemic 
problem, it cannot point to the local site of the disorder (4). Furthermore, as metabolic 
changes precede functional and anatomical changes, it is important that spatially-localized 
changes in pHe be mapped in diseases to improve sensitivity, for example in cancer, where 
pHe change is linked strongly to prognosis and outcome (4). Significantly lower pHe (~6.7) 
in the tumour microenvironment has been reported in the literature. (6) 
Several MRI and MRS techniques have been used to map pH using both exogenous 
substances and endogenous compounds. 31P-MRS has been used to estimate intracellular pH 
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(pHi) using endogenous inorganic phosphate (5). Exogenous 19F compounds have been used 
to quantify pH in vivo using 19F-MRS. A fluorinated derivative of vitamin B6, 6-
fluoropyridoxol has been shown to measure both pHe and pHi in rodent tumours (7). A major 
drawback of this technique is the instability of the fluorinated compounds. Exogenous 
substances such as Imidazole with pH sensitive 1H resonances have been used to quantify 
pHe with the aid of 1H-MRS (8, 9). However, the rather small chemical shift (0.7 ppm) over 
the entire titration range makes this technique less viable at lower field strengths. The 1H-
MRI magnetization transfer technique referred to as Chemical Exchange Saturation Transfer 
(CEST) has also been used to measure pHi based on endogenous amide groups in mouse 
brain under ischemia and with gliomas (10, 11). A more specific CEST technique has been 
used with exogenous substrates such as 5,6-dihydrouacil to measure pHi as well (12). 
Limitations to CEST techniques include high concentration requirement for the CEST agent 
and the need for strong MRI radiofrequency (RF) pulses in order to enhance the saturation 
effect. Similar to CEST, pH dependent relaxation agents such as Gd(DOTA)-4AmP5- have 
been used to measure renal pHe (13) but are highly dependent on favourable 
pharmacokinetics. Overall, the above MRI methods are limited by inherently low signal-to-
noise ratio (SNR).  
One of the more recent pHe measurement techniques utilizes hyperpolarized 13C-bicarbonate 
and Chemical Shift Imaging (CSI) approaches. With advances in Dynamic Nuclear 
Polarization (DNP), polarization of 13C-substrates can be enhanced by up to 100,000 times 
compared to thermal polarization (14). In vivo, the carbonic anhydrase (CA) enzyme 
facilitates equilibration between bicarbonate and carbon dioxide (equation [37]):  
 𝐻𝐶𝑂!! +   𝐻!   𝐶𝐴   𝐶𝑂! +𝐻!0 [37] 
Gallagher et al. have used the CSI method to quantify in vivo pHe in a mouse tumour model 
using hyperpolarized 13C-bicarbonate (H13CO3-) and its metabolite 13C-carbon dioxide 
(13CO2) via the Henderson-Hasselbalch equation (15), based on equation [37]:  
 pH  =  pKa  +  log10  ([H13CO3-­‐]/[13CO2]) [38] 
where H13CO3- and 13CO2 are the signal intensities obtained from the in vivo spectra. 
Unfortunately, CSI is time-consuming (several minutes) and not the most efficient way to use 
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the available non-renewable hyperpolarized magnetization. CSI utilizes a large number of RF 
pulses (typically equal to the number of voxels), acquires a coarse spatial resolution (16 x 16) 
and takes a considerable amount of time (~12 s) to acquire the entire scan, thereby limiting 
SNR due mainly to the short T1 relaxation time of the 13C-bicarbonate (~10 s) and its 
metabolite 13C-carbon dioxide (~10 s) in vivo. Spatial encoding with CSI can be 
accomplished more quickly using echo-planar read-out approaches (16, 17) and spiral read-
out approaches (18, 19). However, echo-planar and spiral CSI still suffer from coarse spatial 
resolution and long acquisition times (e.g. a 12 × 8 × 16 spatial encoding takes 15.4 s) when 
suitable spectral resolution is required for substrates such 13C-pyruvate and its many 
downstream metabolic products (17)  
As the 13C-bicarbonate and 13C-carbon dioxide spectrum is sparse in nature (ie. two peaks), 
the spectral resolution may be traded off for improved spatial resolution. The Dixon approach 
has proven to be useful to image sparse spectra as it exploits prior information of the 
chemical shifts between sparse chemical peaks in a spectrum to optimize readout echo 
spacing for improved efficiency. With this method, n+1 echoes from a sparse spectrum 
containing n substrate peaks can be used to resolve the spatial distribution of each of the 
substrates as well as account for B0 field non-uniformities in the volume of interest. A Dixon 
approach-incorporating IDEAL has been used extensively to separate fat and water images in 
1H-MRI (20-23). Spiral-IDEAL single shot images with echo time shifts in between 
excitations has been used to encode the spectral-spatial concentration of hyperpolarized 13C-
pyruvate and its metabolites (24). With this technique, k-space is encoded in an outward 
spiral fashion following a single excitation RF pulse, which helps preserve the non-
renewable polarization of 13C-metabolites.  
The purpose of this work was to implement a spiral-IDEAL method to map pH utilizing 
hyperpolarized 13C-bicarbonate. Initial validation of the method was performed in thermally-
polarized phantoms by comparing pH measurements using spiral-IDEAL with pH 
measurements obtained using a conventional single-voxel FID-CSI approach. Both above 
MRI methods were compared with measurements obtained using a pH meter. The spiral-
IDEAL technique was then used to map pH with hyperpolarized 13C-bicarbonate and its 
metabolic by-product 13C-carbon dioxide in vitro. Extension of this technique to in vivo 
applications is discussed.  
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4.2 Methods 
4.2.1 Construction of Thermally-Polarized Phantoms 
Five phantoms with pH ranging from 7.02 to 7.96 were constructed for in vitro validation of 
the spiral-IDEAL approach. 1 g of 13C-sodium bicarbonate (Sigma-Aldrich, Oakville, ON, 
CA) was dissolved in 20 ml of deionized H2O. 200 µl ProHance (Bracco Imaging, Anjou, 
QC, CA) was added to the resulting mixture to yield a T1 of 54 ms to improve polarization. 
The mixture was then divided into five equal 4 mL volumes and placed in five 8 ml glass 
vials. An appropriate volume of 1 N HCl was added to adjust the pH of each vial. The 
mixtures were sealed and stored for two weeks to ensure equilibration of H13CO3- and 13CO2. 
The pH of each mixture was verified by measurement using a standard pH meter 
(sympHony, VWR, Mississauga, ON, CA).  
4.2.2 FID-CSI and Spiral-IDEAL pH Mapping 
FID-CSI and spiral-IDEAL were performed using a 3T MRI system (MR750, GEHC, 
Waukesha, WI, USA) equipped with multinuclear hardware and software. FID-CSI and 
spiral-IDEAL acquisitions were performed on each thermally-polarized phantom 
independently using a solenoid 13C coil resonant at a frequency of 32.12 MHz. Imaging 
parameters for the FID-CSI acquisition were as follows: Gaussian pulse, FOV of 12 × 12 cm, 
TR of 1 s, bandwidth of 5 kHz, number of points equal to 2048, flip angle of 90 degree, 
matrix size 1 × 1, number of RF pulses equal to 512, giving a total scan time equal to 8 min 
and 32 s. (total number of scans equal to 512 as one FID per scan) The spiral-IDEAL 
sequence acquires a FID prior to acquisition of the echoes, which aids in reconstruction of 
the spectral information. More details on the spiral-IDEAL sequence can be found in 
Wiesinger et al. (24) Each excitation pulse is followed by a single-shot outward spiral read-
out. The echoes are time shifted from excitation to excitation to encode the spectral 
information. Based on the three echoes and a frequency shift between 13C-biarbonate and 
13C-carbon dioxide of 36 ppm, an echo time shift of 292 µs was determined to yield 
maximum SNR, which was used in the acquisition. A FID was also acquired prior to the 
echoes in every scan, which aids in the reconstruction. The following additional parameters 
were used: FOV of 12 × 12 cm, TR of 250 ms, flip angle of 90 degrees, echo time shift of 
292 µs, number of RF pulses equal to 256, giving a total scan time equal to 1 min and 4 s. 
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(total number of scans equal to 64 as one FID and three echoes per scan)  
4.2.3 Data Processing  
FID-CSI data were processed using SAGETM software (GEHC, Waukesha, WI, USA). 
H13CO3- and 13CO2 peaks were established to be ~36 ppm apart. A spectral apodization of 5 
Hz was used. Peak areas for H13CO3- and 13CO2 were calculated for each vial and the ratio 
was used to compute pH using the Henderson-Hasselbalch equation (equation [38]). The pKa 
was assumed to be 6.17 (15). For spiral-IDEAL, the spectral information in the FID was used 
in the reconstruction of metabolite images. The acquired k-space data were filtered and an 
image-encoding matrix of 128 × 128 was calculated based on the spiral-readout (24). The 
spiral-IDEAL reconstructed metabolite images were further processed off-line using Matlab 
(MathWorks, Natick, MA) to obtain the pH maps. A spectral apodization of 15 Hz was 
performed and a pixel-by-pixel ratio of H13CO3- and 13CO2 intensities was used to compute a 
map of pH using equation [38] with an assumed pKa of 6.17. To reduce noise in the pH map, 
only those voxels with a signal greater than three times the standard deviation of background 
noise in the 13CO2 image were used in the 13CO2 image. Corresponding pixels in the H13CO3- 
image were used to compute the final pH map.  
4.2.4 Hyperpolarized 13C-bicarbonate Preparation and Polarization 
13C-sodium bicarbonate was hyperpolarized using a commercially available DNP system 
(Hypersense, Oxford Instruments, UK). The 13C-sodium bicarbonate (Sigma-Aldrich, 
Oakville, Canada) was initially dissolved in glycerol to yield a concentration of 1.7 M using 
a magnetic stirrer and hot plate (70 °C) and 18 mM trityl radical (OX63, Oxford Instruments, 
UK) was added to the mixture (25). To get the final dissolution, 5 ml of phosphate buffer 
dissolution media with a pH of 7.4 was used to dissolve a 170 µl hyperpolarized sample for a 
final concentration of 58 mM 13C-sodium bicarbonate. The absolute 13C-bicarbonate 
polarization available following DNP at 3T was measured to be between 2-4%. 
4.2.5 In Vitro pH Mapping using Hyperpolarized 13C-bicarbonate  
Immediately following the dissolution, equal amounts of hyperpolarized 13C-bicarbonate 
were mixed with two 4 ml 500 mM sodium phosphate-buffered solutions at pH 6.83 and 7.19 
(measured using the pH meter) respectively containing 10ug of CA enzyme (Isozyme II from 
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bovine erythrocytes, 3000W-A units/mg protein, Sigma Aldrige St. Louis, MO, USA). The 
spiral-IDEAL acquisition was initiated following a delay time of 5 s to allow the H13CO3- 
and 13CO2 to equilibrate. The spiral-IDEAL acquisition was setup with the following 
parameters: field of view of 12 × 12 cm, repetition time of 250 ms, three echoes spaced 292 
µs apart, flip angle of 20 degrees, number of RF pulses equal to 100 and total scan time equal 
to 25 s. (total number of scans equal to 25 as one FID and three echoes per scan) Data 
processing was performed in an identical fashion as described above for the spiral-IDEAL 
imaging of the thermally-polarized phantoms.  
 
4.3 Results 
Figure 4-1 presents a typical thermally-polarized phantom spectrum showing H13CO3- and 
13CO2 peaks separated by 36 ppm which was obtained using the FID-CSI method. Using 
equation [38], pH was computed to be 7.48. Using a standard pH meter, the pH for the same 
solution was measured to be 7.46. The agreement between FID-CSI and actual pH was 
measured for a range of pH values from 7.03 and 7.98 as listed in Table 1. The difference 
between pH measurement by the FID-CSI method and the pH meter ranged from 0.27 to 2.26 
%.  
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Figure 4-1: Spectrum obtained from FID-CSI of the vial with pH meter measurement of 7.46 
(FOV 12 cm, TR 1s, BW 5k, 2048 pts, 512 averages). pH calculated from above spectrum 
based on the ratio of peak areas of H13CO3- and 13CO2 using the Henderson-Hasselbalch 
equation was 7.48 (equation [38]). All pH measurements using FID-CSI method are listed 
and compared with standard pH meter measurements in Table 4-1. 
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Figure 4-2: Cross section pH map of the vials acquired using IDEAL (FOV 12 cm, TR 250 
ms). Mean pH of the vials ranges from 7.03 to 7.98 which all fall within < 0.5 % of the actual 
pH (using a pH meter). Standard deviation in the spiral-IDEAL pH measurements ranges 
from 0.41 for pH of 7.03 to 0.89 for pH of 7.99, as reported in Table 4-1. 
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Table 4-1: pH measured using the pH meter, spiral-IDEAL method and FID-CSI methods 
along with differences are displayed in the columns respectively. Mean and standard 
deviation of the difference in pH between MRI methods and pH meter are shown at the 
bottom. 
Figure 4-2 shows the pH maps derived using spiral-IDEAL acquisitions of the five vials. 
Quantified mean and standard deviation of pH from the spiral-IDEAL pH maps for each vial 
are listed and compared to the standard pH meter reading in Table 1. The difference between 
mean pH measurement by the spiral-IDEAL method and the pH meter ranged from -0.14 to 
0.38 %. The standard deviation of the pH maps obtained using spiral-IDEAL range from 0.41 
for low pH (7.02) to 0.89 for high pH (7.96).  
pH meter 
(actual pH)  
FID-CSI pH 
measurement 
Difference 
from actual 
Spiral-IDEAL pH 
measurement (mean ± 1st 
std. dev. in pH map) 
Difference 
from actual 
7.02 7.08 0.86 % 7.03 ± 0.41 0.14 % 
7.31 7.34 0.41 % 7.30 ± 0.54 -0.14 % 
7.46 7.48 0.27 % 7.45 ± 0.79 -0.13 % 
7.67 7.72 0.52 % 7.68 ± 0.60 0.13 % 
7.96 8.14 2.26 % 7.99 ± 0.89 0.38 % 
 mean 0.86 % mean 0.08 % 
 std. dev. 0.81 % std. dev. 0.22 % 
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Figure 4-3: Linear regression fits between pH measured using pH meter on horizontal axis 
and FID-CSI method on vertical axis (y = 1.009x, R2 = 0.9765) and between pH measured 
using pH meter on horizontal axis and spiral-IDEAL method on vertical axis (y = 0.9917x, 
R2 = 0.9830).  
Figure 4-3 demonstrates pH measurement with the pH meter on the horizontal axis and pH 
measurement with the MRI methods on the vertical axis. The standard deviation of the pH in 
the spiral-IDEAL pH maps is plotted as the error bars. A strong agreement between pH 
measured using the FID-CSI method and the pH meter as well as pH measured using spiral-
IDEAL and the pH meter is observed. A linear regression fit between pH measurement using 
pH meter and FID-CSI method (y = 1.009x, R2 = 0.9765) appears to be similar compared to 
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the linear regression fit between pH measured using the pH meter and the spiral-IDEAL 
approach (y = 0.9917x, R2 = 0.9830).  
Figure 4-4 presents the in vitro pH maps obtained using spiral-IDEAL with hyperpolarized 
13C-bicarbonate. Spiral-IDEAL pH measurements of 6.82 ± 0.21 and 7.16 ± 0.25 (mean ± 
first standard deviation in pH map) compared well to pH meter readings of 6.83 and 7.19 
respectively. The high standard deviation of the hyperpolarized pH maps may be attributable 
to the low polarization level of 13C-bicarbonate that translates to a low 13CO2 SNR.  
 
Figure 4-4: In vitro pH mapping with hyperpolarized 13C-bicarbonate using the spiral-
IDEAL method. Carbonic anhydrase enzyme was added to the phosphate buffer solutions for 
rapid conversion and equilibration of hyperpolarized 13C-bicarbonate to 13C-carbon dioxide. 
Spiral-IDEAL pH measurements of 6.82 ± 0.21 and 7.16 ± 0.25 (mean ± first standard 
deviation in pH map) compared well to pH meter readings of 6.83 and 7.19 respectively.  
 
4.4 Discussion 
The conventional CSI method has been demonstrated in the literature to measure pH using 
hyperpolarized 13C-bicarbonate (15). This was verified here by comparison of the pH 
measurement using the FID-CSI method and a standard pH meter. In this work, a spiral-
IDEAL approach was used based on the known chemical shifts and sparse (i.e. two peak) 
spectrum associated with 13C-bicarbonate to rapidly form (8 times faster than CSI) metabolite 
maps (24). This method was then used to form images of H13CO3- and 13CO2 in thermally-
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polarized phantoms, which were then used in conjunction with the Henderson-Hasselbalch 
equation to compute pH maps (equation [38]). Validation of this method as a tool for 
accurate pH measurement was performed using a standard pH meter, where a strong linear 
regression fit between pH measurement using spiral-IDEAL and standard pH meter 
demonstrated the accuracy of this method (Figure 4-3). 
The pH in each thermally-polarized phantom was independently measured by FID-CSI, 
spiral-IDEAL and a pH meter. The scan time for the FID-CSI is proportional to the number 
of RF pulses used, which in turn is proportional to the matrix size used in the acquisition. 
Spiral-IDEAL presents a distinct advantage with the single-shot readout such that the number 
of RF pulses does not increase with the matrix size. For example, if the FID-CSI approach 
used an 8 x 8 matrix, the total scan time would have been 64 times as much as it has been 
reported. In comparison, the spiral-IDEAL inherently performs pH mapping with a matrix 
size of 128 x 128 with the reported scan time. Additionally, use of FID-CSI with 
hyperpolarized 13C-bicarbonate and a large matrix size would reduce SNR due to the smaller 
voxel and significant T1 decay of hyperpolarized 13C-bicarbonate and 13C-carbon dioxide due 
to the longer scan time.  
It should be noted that both CSI and spiral-IDEAL techniques are highly sensitive to the 
concentration of 13CO2 relative to H13CO3-. As absolute pH increases, the concentration of 
13CO2 decreases, thereby decreasing 13CO2  SNR. This introduces a potential for larger error 
at higher absolute pH compared to lower absolute pH. This phenomenon is observed in Table 
1 where standard deviation of pH was reported for the spiral-IDEAL measurement as an 
estimate of the error in the pH maps. The error was smaller (0.41%) at lower pH (7.02) and 
higher (0.89%) at higher pH (7.96). Additionally, larger differences from actual pH (pH 
meter reading) for the MRI methods (FID-CSI and spiral-IDEAL) are observed for the vial 
with a higher measured pH. The precision and accuracy of the pH maps obtained from spiral-
IDEAL would both likely benefit from a higher number of averages in the MRI acquisition 
of each vial due to the associated increase in 13CO2 SNR.  
In this study, an absolute polarization level of the hyperpolarized 13C-bicarbonate at 3T 
following DNP was between 2% and 4%. This was lower than anticipated and prohibited 
implementation of the technique in vivo in the present study. A lower polarization results in 
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lower SNR for both 13CO2 and H13CO3-, but the 13CO2 SNR affects pH mapping more 
profoundly as it is the lower concentration metabolite. In vitro hyperpolarized 13CO2 SNR for 
the spiral-IDEAL pH map with a mean pH of 7.16 was approximately 2. Higher 13CO2 SNR 
is required at higher pH as an increase in pH leads to reduction in the absolute concentration 
of 13CO2, as dictated by equation [38]. A theoretical increase in in vitro pH from 7.16 to 7.4 
would result in a two-fold increase in 13CO2 SNR thereby allowing improved image quality 
as presented in Figure 4-4. Furthermore, in vivo use would result in a reduction in T1 
relaxation time of the 13CO2 in addition to a longer wait time before imaging following the 
administration of hyperpolarized 13C-bicarbonate. The longer wait time is required for the 
lengthy intravenous injection (~10 s) as well as additional transit time for H13CO3- to move 
into the extracurricular space (estimated 5-7 s). The T1 relaxation time of 13CO2 was 
estimated to reduce from ~30 s in vitro to ~10 s in vivo. We estimate an in vitro 13CO2 SNR 
of ~10 with our current imaging parameters to be sufficient for a suitable in vivo pH map. 
Keeping everything else consistent, this requires a 13C-bicarbonate polarization level of 10-
20%, which has been achieved by others. (26) 
In summary, rapid and accurate pH mapping was demonstrated in phantoms using 
hyperpolarized 13C-bicarbonate with the spiral-IDEAL technique. Comparison of the pH 
measurement using the spiral-IDEAL technique and FID-CSI method as well as the spiral-
IDEAL method and a standard pH meter provide validation for the applicability of this 
method. Accurate in vitro pH mapping with hyperpolarized 13C-bicarbonate provides further 
evidence for the usability of this technique. Application of this technique in vivo may be 
possible with the new DNP polarizers that promise higher polarization of 13C-substrates and 
improved bicarbonate preparations (e.g. Cesium 13C-bicarbonate). (15) 
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Chapter 5: Discussion and Future Work 
In this work, new approaches to quantify in vivo metabolism using hyperpolarized 13C-
substrates (13C-pyruvate and 13C-bicarbonate) have been investigated. These two substrates 
were polarized to a high degree (~10,000-100,000 ppm) for the feasibility of in vivo imaging 
at a magnetic field strength of 3T. The higher polarization was required to compensate for the 
lower gyromagnetic ratio (about ¼ of 1H gyromagnetic ratio – Table 1-2) and lower 
concentration of the 13C-substrates compared to 1H. The gyromagnetic ratio of 13C-substrates 
dictated the thermal polarization of ~2.5 ppm compared to a thermal polarization of ~10 ppm 
for 1H at a magnetic field strength of 3T. Additionally, the higher polarization compensated 
for the lower concentration of 13C-substrates (80 mM for 13C-pyruvate and 60 mM for 13C-
bicarbonate) administered intravenously compared to the concentration of water in vivo 
(estimated at 55 M). In vivo metabolism was quantitated regionally by measuring the ratio of 
lac/pyr following injection of hyperpolarized 13C-pyruvate. In the first study (Chapter 2), a 
higher lac/pyr was observed in rodent lungs and heart two weeks post-irradiation of the entire 
thorax using a 60Co source (14 Gy, one fraction). Radiation Pneumonitis (RP) was confirmed 
qualitatively by macrophage infiltration observed in cell micrographs from irradiated rodents. 
Lack of increase in lac/pyr and lack of macrophage infiltration was observed in the age-
matched healthy cohort. This study was improved upon in Chapter 3 by performing 
conformal radiation therapy, acquisition of regional and longitudinal lac/pyr data and 
acquisition of quantitative histology. The conformal radiation therapy was delivered using a 
modified uCT machine to the right rodent lung (18.5 Gy, two fractions). Regional (left lung, 
right lung and heart) and longitudinal (day 5, 10, 15 and 25 post radiation therapy) 
acquisition of lac/pyr demonstrated organ wide response of injury in the entire lung. Lack of 
increase in lac/pyr in the heart region was observed. Infiltrating macrophages were counted 
in the lower lung regions to obtain quantitative histology that confirmed an organ-wide 
response to the irradiation (left and right lung) and a lack of injury to the heart region. In 
Chapter 4, hyperpolarized 13C-bicarbonate was used to map pH with the spiral-IDEAL 
technique. As bicarbonate is the largest extracellular buffer in vivo, the ratio of bicarbonate to 
its metabolic product of carbon dioxide provides an estimate of the pH. Validation of the 
spiral-IDEAL technique was performed using thermal phantoms with pH varying from 7.02 
to 7.96. The feasibility of this technique was further demonstrated by the use of 
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hyperpolarized 13C-bicarbonate to map pH in vitro with the aid of carbonic anhydrase 
enzyme.  
 
5.1 Radiation Pneumonitis Induced using 60Co 
Chapter 2 describes the study performed to quantify lac/pyr in rodent lungs post-irradiation 
of the whole thorax using 60Co. Pilot experiments were initially performed to select a dose 
that would induce RP in the rodent lungs. Two animals were irradiated in the whole thorax 
(one fraction) with a dose of 12 Gy, 14 Gy and 18 Gy in each cohort for a total of 6 animals. 
12 Gy was deemed to be too low and 18 Gy led to severe adverse symptoms (e.g. weight 
loss, difficulty in breathing). The dose of 14 Gy was chosen to be adequate to induce RP 
without inducing severe adverse symptoms.  
Uniform irradiation to the rodent thorax was performed by providing 7 Gy of dose in the 
supine position and 7 Gy of dose in the prone position for a total dose of 14 Gy. Collimation 
of the 60Co beam was accomplished using a lead block with a circular opening 4 cm in 
diameter. Attempts to avoid irradiation to the liver region of the rodents were made by using 
an animal positioning system. As such, direct exposure of the rodents’ liver to the irradiation 
beam was avoided; although 60Co with its large geometric penumbra could have contributed 
to some dose to the liver region. The thickness of the animal position system (0.75 cm) also 
ensured a build-up region for the high-energy 60Co beam (1.2 MeV).  
The timeline to perform imaging post-irradiation was based on a similar irradiation technique 
in the literature. (1) Two weeks post-irradiation, higher lac/pyr was observed in the lungs and 
the heart region of the irradiated cohort compared to the age-matched healthy cohort. The 
injury was confirmed by macrophage infiltration observed in cell micrographs. A lower paO2 
was also observed in the irradiated cohort compared to the healthy cohort. Irradiation of the 
whole thorax was responsible for the higher lac/pyr in the heart region of the irradiated 
cohort. Although the heart is less radiosensitive than the lungs, the irradiation of the whole 
thorax led to a significant increase in the lac/pyr in the heart region. The parameter of lac/pyr 
was also quantified for the kidneys to estimate systemic effect of the irradiation. Lack of 
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increase in lac/pyr in the kidneys confirmed the localized response to irradiation was limited 
to the thorax region, as measured by lac/pyr.  
A birdcage 13C-RF coil and a surface 1H-RF coil were used to perform MRI and MRSI. The 
surface coils are known for their high sensitivity but a lack of uniformity along the direction 
orthogonal to the surface-plane of the coil. As such they lack B1 uniformity (i.e., intensity) 
along the depth direction. This can be observed in Figure 2-6 as a gradient in the 1H image 
that forms the background image underlaid below the 13C-CSI data in Chapter 2. Although 
13C-RF coil was sufficient to obtain 13C-signal from lungs and the heart region, it lacked the 
SNR needed to delineate 13C-signal from the left and right lung. Nevertheless, this study 
demonstrated the feasibility of hyperpolarized 13C-pyruvate to detect RP using lac/pyr. A few 
areas of improvement that were addressed in the study in Chapter 3 included: a) conformal 
radiation therapy, b) regional acquisition of lac/pyr (left and right lung) using a TORO coil 
approach and, c) acquisition of quantitative histology.  
 
5.2 Radiation Pneumonitis Induced using Conformal 
Radiation Therapy 
The study presented in Chapter 3 improved upon the findings in Chapter 2. In this study, 12 
rodents were irradiated with two fractions of 9.25 Gy each given 24 hours apart in a 
conformal fashion using a modified uCT system. (2) A higher dose than used in the previous 
study (Chapter 2) was used to compensate for the low dose rate of the uCT system (~0.15 
Gy/min) compared to the 60Co (~1.1 Gy/min). (3) The 13C-data was acquired from the left 
lung, the right lung and the heart region of 3 irradiated rodents and 3 healthy age-matched 
rodents each at day 5, 10, 15 and 25 post radiation therapy.  
The irradiation was conformed to the right lung using two parallel-opposed beams with a 
FOV of 14 mm x 14 mm. The energy output of the uCT machine was 140 kVp with a half 
value layer of 6 mm of Aluminum. The procedure was also gated to the breathing cycle of 
the rodents for accurate dose registration. This ensured minimal dose to the contralateral lung 
as well as the heart and the liver region. The low energy of the uCT beam led to high dose 
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deposition in the bones that were present in the irradiation field (ribs, part of spine) due to the 
photoelectric effect.  
The 13C-MRSI data was collecting using the TORO operation, which offered a significantly 
higher SNR that allowed delineation of the 13C-data from the left lung and the right lung. The 
TORO system allowed for rapid switching between the 1H-13C-birdcage transmit coil and a 
13C-surface receive coil for an SNR improvement of ~4 times over the 1H-13C-birdcage 
transmit/receive coil for 13C-MRI. The construction, setup and enhancement using the TORO 
operation are discussed in detail in Appendix A-1. 
An increase in lac/pyr was observed both in the right lung (site of irradiation) and in the left 
lung (contralateral lung) at all time points post-irradiation. A lack of increase in lac/pyr in the 
heart region was also observed at all time points post-irradiation. Blood paO2 did not change 
significantly between the irradiated and healthy cohorts at all time points post irradiation. 
The high dose in the bones did not lead to any adverse effects or change the observed lac/pyr 
in adjoining lung regions. Macrophages counts in the rodent lungs was significantly higher in 
both left and right lungs of the irradiated cohorts compared to the healthy cohorts at all time 
points. It is possible but not likely that the contralateral lung responded directly to the small 
direct dose that it received during the irradiation procedure. The reason that it is unlikely is 
due to the very small volume in addition to the very small dose (< 0.5 Gy) that the 
contralateral lung received during the irradiation procedure, as demonstrated by the dose 
distribution in Figure 3-1. (3) 
The high correlation between the macrophage count and lac/pyr could potentially mean that 
part of the enhanced lac/pyr may be attributable to the increase in metabolically-active 
macrophages infiltrating the lung tissue. Further testing is required to verify the above 
statement. Although the low dose rate of the uCT system did ensure RP in the rodent lungs, a 
lack of fibrosis at 16 week post-irradiation was observed in the histology. This implied that 
most of the injury had been repaired and that the healthy lung was restored. This 
demonstrates that the lac/pyr parameter is quite sensitive to RP in the rodent lungs, as 
confirmed by the histology. Therefore, a very high dose to ensure severe RP is not a 
requirement for observation of the injury using lac/pyr. Nonetheless, a dose escalation study 
would help understand the injury in a better manner.   
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5.3 pH Mapping using 13C-bicarbonate with Spiral-IDEAL  
The study presented in Chapter 4 presents a novel method to map pH using hyperpolarized 
13C-bicarbonate with spiral-IDEAL. The acid-base pair of bicarbonate and carbon dioxide 
forms the largest extracellular buffer in the body. (4) The Henderson-Hasselbalch equation 
can be used to compute the final pH of the bicarbonate-carbon dioxide pair. The spiral-
IDEAL pulse sequence utilizes the available magnetization more efficiently than the CSI 
method. (2) In this work the use of spiral-IDEAL to map pH was validated by comparison of 
pH mapped by this method to pH measured using conventional single-voxel CSI (5) and a 
standard pH meter. In vitro application using hyperpolarized 13C-bicarbonate was also 
validated with a standard pH meter. Although the method itself is feasible, limited 13C-
bicarbonate polarization and concentration prevented us from implementing the technique in 
vivo.  
The recipe of dissolving 13C-bicarbonate in glycerol inherently suffers from a low solubility 
(1.7 M). (6) In addition, the amount of 13C-sodium bicarbonate dissolved in glycerol that can 
be polarized efficiently in the DNP system was limited to 170 ul. Furthermore, the absolute 
polarization for 13C-bicarbonate available at the 3T after the dissolution was measured at 2-
4%. Lastly, the T1 relaxation time for 13C-bicarbonate is ~30 s in vitro reduces to ~10 s in 
vivo.  A combination of the above mentioned factors restricted the in vivo implementation of 
this technique.  
An absolute polarization of 2-4% at the 3T for 13C-bicarbonate resulted in an insufficient 
SNR of 13C-carbon dioxide. As discussed in Chapter 4, based on the in vitro pH map using 
hyperpolarized 13C-bicarbonate with spiral-IDEAL, an increase in 13C-carbon dioxide SNR 
from ~2 to ~10 would yield an adequate in vivo pH map. This would require the polarization 
of 13C-bicarbonate to increase to 10-20% from 2-4%. In addition, other chemical 
formulations with higher solubility (e.g.13C-cesium bicarbonate) could be used to ensure 
higher injectable concentration to yield a better SNR in vivo. As well, newer DNP polarizer 
technologies promising higher polarizations may allow for in vivo pH mapping using 
hyperpolarized 13C-bicarbonate with spiral-IDEAL in future.  
The spiral-IDEAL method described in Chapter 4 reads out the magnetization associated 
with the FID first as well as three echoes to form the set of images of 13C-bicarbonate and 
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13C-carbon dioxide images along with the Bo field correction. (2) Each echo is read out in a 
single-shot spiral fashion after the excitation RF pulse. The spiral encoding is ensured by the 
echo time shift from excitation to excitation. The flip angle for the excitation was chosen to 
be 20 degrees such that it was adequate to form metabolite images while minimizing the 
SNR variation from echo to echo. Minimal SNR variation across three echoes in each data 
set ensured proper reconstruction to formulate the metabolite images. The choice of a smaller 
TR also helped minimize the T1 relaxation effect in the final images. A variable flip angle 
(VFA) scheme could be implemented to ensure uniform SNR across all echoes in future.  
 
5.4 Future Work 
The central questions about the mechanism of RILI motivated quantitation of metabolic 
changes associated with RP, specifically hypoxic tissue environment, inflammation and 
macrophage proliferation in this thesis. However, further work is needed in order to delineate 
the interplay of these mechanistic processes and this will likely be aided by the use of animal 
models of RILI. Quantification of the metabolic signature during RP based on changing total 
dose, dose rate and fractionation scheme could be studied. The data could be collected for a 
longer time span (e.g. zero days to 20 weeks post irradiation procedure) to understand the 
evolution of the underlying disease. This would include lac/pyr ratio and identification of the 
type of proliferating macrophages. The hypothesis that part of the lac/pyr enhancement may 
be a result of highly metabolic infiltrating macrophages could also be tested. Overlay of 
lac/pyr data over a) the hypoxia map from histology, and b) the macrophage map from 
histology and comparison of the two data sets would help decode the origin of lac/pyr 
changes in RP. Additional studies could be performed to profile the inflammatory cytokines, 
type II pneumocytes endothelial cells and fibroblasts in a similar manner to test the 
relationship between lac/pyr and the evolution of these physiological parameters. A study 
could also be performed to evaluate the metabolic signature following administration of 
radioprotector chemical species such as Superoxide Dismutase post-irradiation. (1) 
Establishment of the mechanistic nature of the injury in more controlled animal models 
would result in a better understanding of RP. A deeper level of understanding would benefit 
the clinical studies, where the injury often progresses in a more complex manner than in the 
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animal models due to other confounding factors. Some of these confounding factors include 
the risk factors listed in Table 1-1 under the patient category. Animal models of RILI with 
low paO2 prior to radiation therapy along with a variable conformation of the radiation 
therapy across the lung may help elucidate these clinical risk factors in a better manner.  
Clinical use of hyperpolarized 13C-pyruvate MRI for detection of RP could aid in real-time 
monitoring of ongoing radiation therapy of breast cancer, lung cancer and other thoracic 
cancers that may be susceptible to RILI. The information could be used as feedback for 
modification of the radiation therapy (or chemotherapy) plan or to determine whether anti-
inflammatory drugs would help (e.g. corticosteroids). As every patient may have a slightly 
different physiological make-up, 13C-pyruvate MRI could assist with personalized treatment 
where the metabolism of each patient could be recorded and used in the ongoing therapeutic 
intervention. The non-ionizing nature of MRI also permits repeated scans for continuous 
monitoring of a patient, which may not be possible with X-ray based modalities such as PET 
and CT. Continuous monitoring may be important to track the evolution of both the tumour 
response and the RP in cancer patients. Cancer cells may begin to demonstrate lower lac/pyr 
post therapeutic intervention, as demonstrated in the literature with other cancer cell lines, (7) 
while onset of RP leads to higher lac/pyr post radiation therapy, as demonstrated in this 
thesis. In addition, hyperpolarized 13C-bicarbonate could be used in the clinic to map pH of 
tumours undergoing radiation therapy, as pH plays a vital role in tumour progression and 
therapy. (8) Successful phase I clinical trials for the use of hyperpolarized 13C-substrates in 
detection of prostate cancer (9) may pave the way for use of this exciting technique in a 
variety of human diseases, including as RP, in the near future.  
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Appendix A-1: 13C-SNR enhancement using the 
Transmit-Only/Receive-Only (TORO) RF coil 
configuration  
Chapter 2 used a switch-tuned 13C-1H-birdcage RF coil that could be rapidly switched 
between anatomical imaging mode (1H) and metabolic imaging mode (13C) by use of a PN-
junction with isolation region diodes. This coil was designed and constructed by Heeseung 
Lim. In addition, the fast switching mechanism was exploited to operate the birdcage coil as 
a 13C-transmit-only coil with a 13C-surface coil for reception of the 13C-signal, otherwise 
known as the Transmit-only/Receive-only (TORO) configuration. The surface coil and the 
fast switching mechanism between the birdcage coil and the surface coil were designed and 
constructed by Kundan Thind. Overall, the combined system is capable of TORO operation 
for 13C-imaging and spectroscopy and ordinary transmit/receive operation as a 1H coil, which 
results in an enhanced 13C-SNR.  
During the transmit phase of the TORO operation, the transmit coil must be tuned to the 
resonant frequency while the receive coil is de-tuned and during the receive phase of the 
TORO operation, the alternate is true. This rapid switching was accomplished by the 
application of a direct current bias to the diodes in the RF hardware circuit. The bias current 
tuned the 13C-1H birdcage transmit coil to resonate at the 13C-frequency while simultaneously 
de-tuned the 13C-surface receive coil. The bias current required for the TORO operation was 
provided by the MRI system but was not sufficient to bias all the diodes. For a fully 
functioning TORO operation, the bias current was amplified using an additional fast 
switching circuit and an external power supply in order to bias all the diodes. The complete 
circuit diagram is shown in Figure A-1. During the transmit phase, the transmit RF pulse 
from the scanner (consisting of both an alternating current component at the resonant 
frequency and a direct current component) was filtered using a tank circuit to remove the 
alternating current component. This yielded a clean direct current bias that was amplified 
using a metal oxide semiconductor field effect transistor circuit and an Agilent U8002A 
power supply. The amplified bias was then used to drive the 13C-1H-birdcage transmit coil 
and the 13C-surface receive coil. The orientation of the diodes on the coils was arranged such 
that with the onset of the transmit pulse (the direct current bias being in the ‘ON’ state) the 
birdcage transmit coil was tuned to the 13C-resonant frequency and the 13C-surface coil was 
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de-tuned. After the transmit RF pulse, the direct current bias would switch to the ‘OFF’ state 
which de-tuned the 13C-birdcage coil (it would switch to 1H frequency) and re-tuned the 13C-
surface coil for signal reception.  
 
Figure A-1: Detailed outline of the TORO operation. A tank circuit filters the alternating 
current component from the transmit pulse. The resulting direct current bias was amplified 
using a metal oxide semiconductor field effect transistor circuit and an Agilent U8002A 
power supply. The amplified direct current bias was supplied to the 1H-13C-birdcage coil and 
the 13C-surface coil that led to a tuned 1H-13C-birdcage coil (at 13C-resonant frequency for 
efficient transmit) and a de-tuned 13C-surface receive coil. After the transmit pulse, the 1H-
13C-birdcage coil was de-tuned (switches back to 1H-resonant frequency) and 13C-surface coil 
was re-tuned to 13C-resonant frequency for efficient reception. Figure courtesy of Heeseung 
Lim. 
The SNR enhancement was calculated for the TORO operation over the regular 
transmit/receive with the birdcage 13C-1H-birdcage coil using a thermally-polarized 13C-
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sodium acetate phantom. 2D 1H images were acquired for localization purposes in the 
coronal plane with a 128 mm × 128 mm FOV and 40 mm slice thickness that resulted in an 
in-plane resolution of 0.5 mm/voxel. A fast gradient echo sequence was employed with the 
following parameters: TR = 34 ms, TE = 4.1 ms, flip angle = 90 degree and 16 averages. For 
13C-imaging, the in-plane resolution was reduced to 1.0 mm/voxel over the same FOV and 
with the same slice thickness as the coronal 1H
 
images. Images of the phantoms were 
acquired using a broad-banded fast gradient echo sequence with TR = 34 ms, TE = 2.3 ms, 
flip angle = 90 degree and 64 averages. Figure A-2 shows the 13C-images acquired from the 
transmit/receive operation of the 13C-1H-birdcage coil and the TORO setup. The 13C-SNR 
was computed to be 4.2 times higher in the TORO operation than the transmit/receive 
operation of the 13C-1H-birdcage coil. 
 
Figure A-2: 13C-2D-coronal image acquired using transmit/receive operation of the 13C-1H-
birdcage coil is shown on the left and a similar image acquired using the TORO operation 
(with identical sequence parameters) is shown on the right. The TORO operation 
demonstrates an SNR improvement by a factor of 4.2 times compared to the transmit/receive 
configuration using the 13C-1H-birdcage coil. Figure courtesy of Heeseung Lim. 
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Appendix A-2: Statistical tests used in the thesis  
 
A brief introduction of the paired t-tests and mixed analysis of variance used in this thesis is 
given below. The interested reader is referred to (1) for detailed reading.  
 
Chapter 2 and 3 used paired two tailed t-tests to verify the significant differences between the 
healthy and irradiated cohorts. The significance differences are verified using the p value 
with a value of less than 0.05 generally considered as significant. The test assumes that the 
samples follow a normal distribution, are independently collected and identically distributed. 
The paired test consists of samples that are matched in pairs of similar units of measurement. 
For the thesis, the samples from healthy and irradiated cohorts were paired with 
administration of irradiation being the only difference between the two cohorts. Two tailed t-
tests are less sensitive to directional change compared to one tailed t-tests. Thus verification 
of directional change by two tailed t-tests instead of one tailed t-tests ensured further 
validation of the change between healthy and irradiated cohorts.  
 
Mixed analysis of variance was performed in Chapter 3 to test for significant differences 
between irradiated cohorts over time. In mixed analysis of variance, the difference between 
two independent cohorts is tested while subjecting the cohorts to repeated measures. The two 
factors include one that varies between-subjects and the other that varies within-subjects. The 
test assumes that the samples follow a normal distribution, are independently collected and 
are identically distributed. Adjustments could be made if any of these assumptions are 
violated prior to the test.  
 
Some of the cohorts tested may not have met all the assumptions required for the two tailed 
paired t-tests and mixed analysis of variance due to the small number of samples. Increasing 
the sample size should ensure validity of the assumptions or corrections required for the 
assumptions before testing for the significant differences between cohorts.  
 
(1)  Steel RG, Torrie JH and Dickey DA. Principles and Procedures of Statistics: A 
Biometrical Approach. McGraw-Hill; 1996  
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early Radiation-Induced Lung Injury post conformal radiation therapy of the lung. Kundan 
Thind*, Elaine Hegarty, Albert Chen, Heeseung Lim, Francisco Martinez, Michael Jensen, 
Eugene Wong, Timothy Scholl, Giles Santyr. 
 
10th Annual CIHR Strategic Training Program in Cancer Research and Technology 
Transfer Research and Education day, June 2013.  
Detecting early metabolic changes in Radiation-Induced Lung Injury using hyperpolarized 
13C-pyruvate post conformal radiation therapy of the lung. Kundan Thind*, Michael Jensen, 
Elaine Hegarty, Albert Chen, Heeseung Lim, Francisco Martinez, Jake VanDyk, Eugene 
Wong, Timothy Scholl, Giles Santyr. 
 
2013 International Pulmonary Imaging Workshop, May 2013.  
Anatomical, Functional and Metabolic MRI of Lung Injury using Hyperpolarized Nuclei. 
Giles Santyr, Kundan Thind, Michael Jensen, Albert Chen, Elaine Hegarty, Timothy Scholl, 
Jake VanDyk, Eugene Wong.  
 
Radiological Society of North America, November 2012.  
In Vivo Magnetic Resonance Imaging of Hyperpolarized Choline and Monitoring of 
Metabolism. Trevor Wade, Hyla Allouche-Arnon, Lanette Friesen Waldner, Charles A 
McKenzie, Kundan Thind, Alexei Ouriadov, Albert Chen, J. Moshe Gomori, and Rachel 
Katz-Brull. 
 
World Molecular Imaging Conference, September 2012.  
In Vivo Magnetic Resonance Imaging of Hyperpolarized Choline and Monitoring of 
Metabolism. Trevor Wade, Hyla Allouche-Arnon, Lanette Friesen Waldner, Charles A 
McKenzie, Kundan Thind, Alexei Ouriadov, Albert Chen, J. Moshe Gomori, and Rachel 
Katz-Brull. 
 
The Third International Workshop on Metabolic Imaging, July 2012.  
Quantification of pH in the rat thorax using hyperpolarized 13C-bicarbonate.  
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Kundan Thind*, Francisco Martinez, Albert Chen, Alexei Ouriadov, Timothy Scholl and 
Giles Santyr.  
 
The International Society for Magnetic Resonance in Medicine, May 2012.  
In Vivo Imaging of Hyperpolarized 13C labeled Choline and Monitoring of Metabolism. 
Trevor Wade, Hyla Allouche-Arnon, Lanette Friesen Waldner, Charles A McKenzie, Kundan 
Thind, Alexei Ouriadov, Albert Chen, J. Moshe Gomori, and Rachel Katz-Brull. 
 
Imaging Network of Ontario, February 2012.  
Measurement of pH using hyperpolarized 13C Magnetic Resonance Spectroscopy. Kundan 
Thind*, Francisco Martinez, Albert Chen, Alexei Ouriadov, Timothy Scholl and Giles Santyr.  
 
Canadian Organization of Medical Physicists, July 2011.  
Using hyperpolarized 13C Magnetic Resonance Spectroscopy to detect  
Radiation-Induced-Lung-Injury at an early stage. Kundan Thind*, Albert Chen, Alexei V. 
Ouriadov, Lanette Friesen-Waldner, Matthew Fox, Eugene Wong, Giles Santyr. 
 
Imaging Network of Ontario, January 2011. 
Using hyperpolarized Carbon-13 Magnetic Resonance spectroscopy to probe in-vivo 
metabolism in real Timothy e. Kundan Thind*, Alexei V. Ouriadov, Lanette Friesen-
Waldner, Matthew Fox, Eugene Wong, Giles Santyr. 
 
Canadian Organization of Medical Physicists, June 2010.  
Hyperpolarized 13C Magnetic Resonance Imaging and Dynamic Spectroscopy for Detection 
of Radiation-Induced Lung Injury. Kundan Thind*, Alexei V. Ouriadov, Lanette Friesen-
Waldner, Matthew Fox, Eugene Wong, Giles Santyr. 
 
Posters (Refereed)  
 
The International Society for Magnetic Resonance in Medicine, April 2013.  
Mapping changes in lactate-to-pyruvate signal ratio using hyperpolarized 13C-pyruvate in 
early Radiation-Induced Lung Injury post conformal radiation therapy of the lung. Kundan 
Thind*, Elaine Hegarty, Albert Chen, Heeseung Lim, Francisco Martinez, Michael Jensen, 
Eugene Wong, Timothy Scholl, Giles Santyr. 
 
The International Society of Magnetic Resonance in Medicine, April 2013. 
Detecting and characterizing therapeutic response to radio- & chemotherapies with 
hyperpolarized [1-13C] pyruvate in rat glioma model. Heeseung Lim, Kundan Thind, Timothy 
Yeung, Francisco Martinez, Timothy J. Scholl. 
 
The International Society of Magnetic Resonance in Medicine, April 2013. 
A Transmit-Only/Receive-Only Radiofrequency Coil Configuration for Hyperpolarized 
129Xe Imaging of the Rodent Lung. Ozkan Doganay, Kundan Thind, Trevor Wade, Alexei 
Ouriadov, Giles Santyr. 
 
The International Society of Magnetic Resonance in Medicine, April 2013. 
Transmit-only receive-only operation of a switch-tuned 13C-1H radiofrequency coil for 
improved in vivo 13C-spectroscopy. Heeseung Lim, Kundan Thind, Francisco Martinez, 
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Timothy Scholl.   
 
The International Society of Magnetic Resonance in Medicine, April 2013. 
T1 Nuclear Magnetic Resonance Dispersion of Hyperpolarized 13C-Sodium Bicarbonate. 
Francisco Martinez, Narayan Chattergoon, Kundan Thind, Albert Chen, Timothy Scholl.  
 
The International Society of Magnetic Resonance in Medicine, April 2013. 
Hyperpolarised [1-13C]-Pyruvate Metabolism in Brown Fat. Lanette Friesen-Waldner, Trevor 
Wade, Curtis Wiens, Kundan Thind, Jacqueline Harris, Kevin Sinclair, Collin McCurdy, 
Albert Chen, Nica Borradaile, Charles McKenzie. 
 
The International Society of Magnetic Resonance in Medicine, April 2013. 
3D Co-Registration of MRI and Histology in a Mouse Model of Obesity and Non-Alcoholic 
Fatty Liver Disease. Eli Gibson, Lanette Friesen-Waldner, Amanda Hamilton, Emeline 
Ribot, Trevor Wade, Curtis Wiens, Kundan Thind, Jacqueline Harris, Nica Borradaile, 
Charles A McKenzie, and Aaron Ward.  
 
Imaging Network of Ontario, January 2013. (Awarded 3rd place in poster competition) 
Use of IDEAL technique with Hyperpolarized 13C-bicarbonate to map pH. 
Kundan Thind*, Alexei Ouriadov, Albert Chen, Heeseung Lim, Curtis Wiens, Francisco 
Martinez, Charles McKenzie, Timothy Scholl, Giles Santyr. 
 
Imaging Network of Ontario, January 2013.  
Monitoring Therapeutic Response in a Rat Model of Glioblastoma Multiforme with 
Hyperpolarized [1-13C] Pyruvate. Heeseung Lim, Kundan Thind, Timothy Yeung, Francisco 
Martinez, Timothy J. Scholl.  
 
Imaging Network of Ontario, January 2013.  
A Transmit-Only/Receive-Only Radiofrequency Coil Configuration for Hyperpolarized 
129Xe Magnetic Resonance Imaging. Ozkan Doganay, Kundan Thind, Trevor Wade, Alexei 
Ouriadov, Giles Santyr. 
 
The Third International Workshop on Metabolic Imaging, July 2012.  
Quantification of pH in the rat thorax using hyperpolarized 13C-bicarbonate.  
Kundan Thind*, Francisco Martinez, Albert Chen, Alexei Ouriadov, Timothy Scholl and 
Giles Santyr.  
 
American Thoracic Society, May 2012.  
Detection of Radiation-Induced Lung Injury using Hyperpolarized 13C Magnetic Resonance 
Spectroscopy and Imaging. Kundan Thind*, Albert Chen, Alexei V. Ouriadov, Lanette 
Friesen-Waldner, Matthew Fox, Eugene Wong, Giles Santyr. 
 
The International Society of Magnetic Resonance in Medicine, May 2012. 
Switch-Tuned Dual-Frequency Birdcage RF Coil for 13C and 1H Imaging. Heeseung Lim, 
Kundan Thind, Jian-xiong Wang, Andrew Alejski, Francisco Martinez, and Timothy Scholl. 
 
Cancer Care Ontario, April 2010. 
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Hyperpolarized 13C Magnetic Resonance Imaging and Dynamic Spectroscopy for Detection 
of Radiation-Induced Lung Injury. Kundan Thind*, Alexei V. Ouriadov, Lanette Friesen-
Waldner, Matthew Fox, Eugene Wong, Giles Santyr.  
 
 
 
 
 
Scholarships and Awards  
Western University, London  
 
May 2013 – April 2014, OGS 
$15000 towards PhD program (declined) 
January 2013, Poster Presentation award at ImNO 
   $100 for 3rd place in poster presentation   
September 2012 – August 2013, CIHR strategic training program in CaRTT  
$26700 total funding per year towards PhD program  
May 2012 – April 2013, OGS 
$15000 towards PhD program  
May 2011 – April 2012, OGS 
$15000 towards PhD program  
September 2009 – present, Schulich Graduate Scholarship 
$6,938 for school tuition per year 
September 2009 – August 2010, NSERC CGS-M 
$17500 towards Masters program  
 
McMaster University 
 
May 2008 – August 2008, NSERC USRA 
$4500 towards research (declined) 
September 2006 – April 2007, Senate scholarship 
$800 for academic excellence 
September 2008 – April 2009, Hooker’s award 
   $1500 for academic excellence 
September 2005 – April 2009, Queen Elizabeth II scholarship 
$14000 for academic excellence 
September 2005 – April 2007, Nortel Networks Entrance Scholarship 
$6000 for academic excellence  
September 2005 – April 2007, McMaster President’s Award 
$6000 for academic excellence  
 
Teaching Experience 
 
January 2012 – April 2013, Teaching Assistant, Western University, London 
. Medical Biophysics 3507, Oxygen transportation in blood  
. Taught analytical diffusion problems and implementation in Matlab 
. Led the question and answer session and marked assignments  
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September 2007 – April 2009, Teaching Assistant, McMaster University, Hamilton 
. Engineering 1DO4, basic algorithms with the aid of C sharp 
. Led classroom of 40-50 students as a tutorial teaching assistant 
. Served as a question and answer session teaching assistant  
 
 
Additional Research Experience 
 
August 2009 – April 2013, Research Assistant, Robarts Research Institute, London 
. Design and construction of 1H, 3He, 129Xe coils for low field (0.075T) and 3T 
MRI  
. Repair and maintenance of multinuclear MRI hardware  
 
May 2007 – August 2007, Research and Development, Evertz Microsystems, Burlington 
. Employed as summer CO-OP Design Engineer 
. C++ programming for menu structures of LCD displays  
 
May 2006 – Aug 2006, Research and Development, Evertz Microsystems, Burlington 
. Employed as summer CO-OP Design Engineer 
. Emphasis on C++ and VHDL programming  
 
Volunteer Leadership Experience 
 
September 2009 – April 2011, Co-President, Western Punjabi Association, Western 
Ontario, London 
. Oversaw the operations and provided direction to committee members 
. Organized and led fundraising events  
 
September 2007 – April 2009, Vice President Social, BEAMS, McMaster University, 
Hamilton 
. BEAMS - Biomedical Engineering at McMaster Society 
. Organized and collaborated social events  
. Managed volunteers for smooth operation during the social events 
 
May 2008 – April 2009, Treasurer, Engineer World Health, McMaster Chapter, McMaster 
University, Hamilton 
. Managed allocation of financial resources 
. Organized and helped in fundraising events 
 
September 2006 – November 2008, Captain, Outdoor Soccer team, Intramural sports, 
McMaster University, Hamilton 
. Led the intramural soccer team for 3 years 
. Made it to the semi-finals each season 
 
 
